CN107259058A - 先进的胶基糖形成 - Google Patents
先进的胶基糖形成 Download PDFInfo
- Publication number
- CN107259058A CN107259058A CN201710386468.2A CN201710386468A CN107259058A CN 107259058 A CN107259058 A CN 107259058A CN 201710386468 A CN201710386468 A CN 201710386468A CN 107259058 A CN107259058 A CN 107259058A
- Authority
- CN
- China
- Prior art keywords
- roller
- gum
- matrix
- acid
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 54
- 235000015218 chewing gum Nutrition 0.000 claims abstract description 109
- 229940112822 chewing gum Drugs 0.000 claims abstract description 106
- 238000000034 method Methods 0.000 claims abstract description 73
- 239000000463 material Substances 0.000 claims description 273
- 239000011159 matrix material Substances 0.000 claims description 260
- 239000000203 mixture Substances 0.000 claims description 212
- 235000000346 sugar Nutrition 0.000 claims description 157
- 230000008859 change Effects 0.000 claims description 125
- 238000000926 separation method Methods 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims 3
- 238000004513 sizing Methods 0.000 abstract description 27
- 239000000796 flavoring agent Substances 0.000 description 113
- 235000019634 flavors Nutrition 0.000 description 113
- 229920000591 gum Polymers 0.000 description 95
- 239000000126 substance Substances 0.000 description 78
- 239000003795 chemical substances by application Substances 0.000 description 73
- -1 sorva Substances 0.000 description 64
- 235000003599 food sweetener Nutrition 0.000 description 53
- 239000003765 sweetening agent Substances 0.000 description 53
- 239000000047 product Substances 0.000 description 51
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 34
- 235000009508 confectionery Nutrition 0.000 description 34
- 238000002156 mixing Methods 0.000 description 34
- 239000002253 acid Substances 0.000 description 31
- 229920001971 elastomer Polymers 0.000 description 31
- 239000000806 elastomer Substances 0.000 description 29
- 239000001993 wax Substances 0.000 description 27
- 239000003814 drug Substances 0.000 description 26
- 239000003921 oil Substances 0.000 description 24
- 235000019198 oils Nutrition 0.000 description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 20
- 125000003147 glycosyl group Chemical group 0.000 description 19
- 239000004615 ingredient Substances 0.000 description 19
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 18
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 18
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 18
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 18
- 239000000284 extract Substances 0.000 description 17
- 235000002639 sodium chloride Nutrition 0.000 description 17
- 235000019640 taste Nutrition 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000049 pigment Substances 0.000 description 16
- 238000007493 shaping process Methods 0.000 description 16
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 15
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 14
- 244000246386 Mentha pulegium Species 0.000 description 14
- 235000016257 Mentha pulegium Nutrition 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 238000001816 cooling Methods 0.000 description 14
- 239000003925 fat Substances 0.000 description 14
- 235000019197 fats Nutrition 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 229940041616 menthol Drugs 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 14
- 238000012545 processing Methods 0.000 description 14
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 13
- 235000004357 Mentha x piperita Nutrition 0.000 description 13
- 239000004902 Softening Agent Substances 0.000 description 13
- 239000000945 filler Substances 0.000 description 13
- 239000003292 glue Substances 0.000 description 13
- 235000001050 hortel pimenta Nutrition 0.000 description 13
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 13
- 239000004014 plasticizer Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 150000001299 aldehydes Chemical class 0.000 description 11
- 235000013399 edible fruits Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229960004793 sucrose Drugs 0.000 description 11
- 244000131522 Citrus pyriformis Species 0.000 description 10
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 10
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 239000005720 sucrose Substances 0.000 description 10
- 150000005846 sugar alcohols Chemical class 0.000 description 10
- 229940088594 vitamin Drugs 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 150000003722 vitamin derivatives Chemical class 0.000 description 10
- 235000005979 Citrus limon Nutrition 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- 244000269722 Thea sinensis Species 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 9
- 235000009499 Vanilla fragrans Nutrition 0.000 description 9
- 244000263375 Vanilla tahitensis Species 0.000 description 9
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 9
- 235000010216 calcium carbonate Nutrition 0.000 description 9
- 239000001506 calcium phosphate Substances 0.000 description 9
- 235000010449 maltitol Nutrition 0.000 description 9
- 235000019605 sweet taste sensations Nutrition 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 229940124584 antitussives Drugs 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 description 8
- 238000005520 cutting process Methods 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 8
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- 239000002023 wood Substances 0.000 description 8
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 7
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 7
- 235000010358 acesulfame potassium Nutrition 0.000 description 7
- 239000000619 acesulfame-K Substances 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 238000004049 embossing Methods 0.000 description 7
- 125000005456 glyceride group Chemical group 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000000845 maltitol Substances 0.000 description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 229960003975 potassium Drugs 0.000 description 7
- 235000007686 potassium Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000012744 reinforcing agent Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 235000019408 sucralose Nutrition 0.000 description 7
- 235000020357 syrup Nutrition 0.000 description 7
- 239000006188 syrup Substances 0.000 description 7
- 235000010447 xylitol Nutrition 0.000 description 7
- 239000000811 xylitol Substances 0.000 description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 7
- 229960002675 xylitol Drugs 0.000 description 7
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 6
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 6
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 6
- 239000004606 Fillers/Extenders Substances 0.000 description 6
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 239000002830 appetite depressant Substances 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 230000001055 chewing effect Effects 0.000 description 6
- 229930002875 chlorophyll Natural products 0.000 description 6
- 235000019804 chlorophyll Nutrition 0.000 description 6
- 229940106705 chlorophyll Drugs 0.000 description 6
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 6
- 229940035436 maltitol Drugs 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 6
- 230000035807 sensation Effects 0.000 description 6
- 235000019615 sensations Nutrition 0.000 description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 235000002906 tartaric acid Nutrition 0.000 description 6
- 239000011975 tartaric acid Substances 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 235000016068 Berberis vulgaris Nutrition 0.000 description 5
- 241000335053 Beta vulgaris Species 0.000 description 5
- 241000167854 Bourreria succulenta Species 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 244000183685 Citrus aurantium Species 0.000 description 5
- 235000007716 Citrus aurantium Nutrition 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000004376 Sucralose Substances 0.000 description 5
- 244000078534 Vaccinium myrtillus Species 0.000 description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 235000014787 Vitis vinifera Nutrition 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 5
- 235000010210 aluminium Nutrition 0.000 description 5
- 230000001458 anti-acid effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000003434 antitussive agent Substances 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 235000019693 cherries Nutrition 0.000 description 5
- 238000005660 chlorination reaction Methods 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 235000017168 chlorine Nutrition 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 230000000994 depressogenic effect Effects 0.000 description 5
- 150000002118 epoxides Chemical class 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 238000001125 extrusion Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000001530 fumaric acid Substances 0.000 description 5
- 235000011087 fumaric acid Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000905 isomalt Substances 0.000 description 5
- 235000010439 isomalt Nutrition 0.000 description 5
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 5
- 239000001630 malic acid Substances 0.000 description 5
- 235000011090 malic acid Nutrition 0.000 description 5
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 5
- 239000008601 oleoresin Substances 0.000 description 5
- 235000019477 peppermint oil Nutrition 0.000 description 5
- 230000008447 perception Effects 0.000 description 5
- 229960003742 phenol Drugs 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 238000010008 shearing Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 description 5
- 239000004408 titanium dioxide Substances 0.000 description 5
- 235000010215 titanium dioxide Nutrition 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 241000193749 Bacillus coagulans Species 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 4
- 241000723346 Cinnamomum camphora Species 0.000 description 4
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 4
- 241001672694 Citrus reticulata Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 229920000161 Locust bean gum Polymers 0.000 description 4
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 4
- 239000004384 Neotame Substances 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 235000012550 Pimpinella anisum Nutrition 0.000 description 4
- 240000004760 Pimpinella anisum Species 0.000 description 4
- 240000000111 Saccharum officinarum Species 0.000 description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 4
- CZNLTCTYLMYLHL-UHFFFAOYSA-N [6]-Paradol Chemical compound CCCCCCCC(=O)CCC1=CC=C(O)C(OC)=C1 CZNLTCTYLMYLHL-UHFFFAOYSA-N 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000004411 aluminium Substances 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000001387 anti-histamine Effects 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 229940054340 bacillus coagulans Drugs 0.000 description 4
- 235000021014 blueberries Nutrition 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- 235000011010 calcium phosphates Nutrition 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 229960002504 capsaicin Drugs 0.000 description 4
- 229930016911 cinnamic acid Natural products 0.000 description 4
- 235000013985 cinnamic acid Nutrition 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 229940108928 copper Drugs 0.000 description 4
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 4
- 150000002016 disaccharides Chemical class 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 235000003869 genetically modified organism Nutrition 0.000 description 4
- 229950006191 gluconic acid Drugs 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 4
- 235000010420 locust bean gum Nutrition 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 235000001055 magnesium Nutrition 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 229930007503 menthone Natural products 0.000 description 4
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 4
- 239000011785 micronutrient Substances 0.000 description 4
- 235000013369 micronutrients Nutrition 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 229920001206 natural gum Polymers 0.000 description 4
- 235000019412 neotame Nutrition 0.000 description 4
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 4
- 108010070257 neotame Proteins 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 235000011007 phosphoric acid Nutrition 0.000 description 4
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 4
- 235000019192 riboflavin Nutrition 0.000 description 4
- 239000002151 riboflavin Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229940083542 sodium Drugs 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229960005137 succinic acid Drugs 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 235000012222 talc Nutrition 0.000 description 4
- 206010044652 trigeminal neuralgia Diseases 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 3
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 3
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 description 3
- WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- 244000056139 Brassica cretica Species 0.000 description 3
- 235000003351 Brassica cretica Nutrition 0.000 description 3
- 235000003343 Brassica rupestris Nutrition 0.000 description 3
- 241000522254 Cassia Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 3
- 240000002943 Elettaria cardamomum Species 0.000 description 3
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 239000000899 Gutta-Percha Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 235000014749 Mentha crispa Nutrition 0.000 description 3
- 244000078639 Mentha spicata Species 0.000 description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 description 3
- 240000000342 Palaquium gutta Species 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 description 3
- 240000002657 Thymus vulgaris Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 244000195452 Wasabia japonica Species 0.000 description 3
- 235000000760 Wasabia japonica Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 229960004998 acesulfame potassium Drugs 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 235000012665 annatto Nutrition 0.000 description 3
- 239000002249 anxiolytic agent Substances 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 235000013735 beta-apo-8'-carotenal Nutrition 0.000 description 3
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 235000005300 cardamomo Nutrition 0.000 description 3
- 235000012730 carminic acid Nutrition 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 229960004126 codeine Drugs 0.000 description 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Natural products C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 229960001985 dextromethorphan Drugs 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 3
- 229940038472 dicalcium phosphate Drugs 0.000 description 3
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940030275 epigallocatechin gallate Drugs 0.000 description 3
- 235000012732 erythrosine Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 229940093503 ethyl maltol Drugs 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000009432 framing Methods 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 229920000588 gutta-percha Polymers 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000010187 litholrubine BK Nutrition 0.000 description 3
- 239000004335 litholrubine BK Substances 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 229940043353 maltol Drugs 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 229960001855 mannitol Drugs 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229960002900 methylcellulose Drugs 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 235000010460 mustard Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 235000017807 phytochemicals Nutrition 0.000 description 3
- 229930000223 plant secondary metabolite Natural products 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 3
- 229960002799 stannous fluoride Drugs 0.000 description 3
- 229940114926 stearate Drugs 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000001585 thymus vulgaris Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 2
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical class O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 description 2
- YDDUMTOHNYZQPO-UHFFFAOYSA-N 1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid Natural products OC1C(O)CC(C(O)=O)(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000193417 Brevibacillus laterosporus Species 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 244000302413 Carum copticum Species 0.000 description 2
- 235000007034 Carum copticum Nutrition 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 2
- SITQVDJAXQSXSA-CEZRHVESSA-N Cynarin Natural products O[C@@H]1C[C@@](C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)(OC(=O)C=Cc3cccc(O)c3O)C(=O)O SITQVDJAXQSXSA-CEZRHVESSA-N 0.000 description 2
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 2
- 229930182843 D-Lactic acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 2
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 241001465251 Ephedra sinica Species 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- 239000004211 Flavoxanthin Substances 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 2
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 241001134659 Lactobacillus curvatus Species 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 239000004594 Masterbatch (MB) Substances 0.000 description 2
- 244000217433 Melampodium divaricatum Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 108050004114 Monellin Proteins 0.000 description 2
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- VQEONGKQWIFHMN-UHFFFAOYSA-N Nordihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCC(C)C)=CC=C1O VQEONGKQWIFHMN-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 240000000783 Origanum majorana Species 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000006990 Pimenta dioica Nutrition 0.000 description 2
- 240000008474 Pimenta dioica Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004216 Rhodoxanthin Substances 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- SMTZFNFIKUPEJC-UHFFFAOYSA-N Roxane Chemical compound CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1 SMTZFNFIKUPEJC-UHFFFAOYSA-N 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 241000204115 Sporolactobacillus inulinus Species 0.000 description 2
- 241001464969 Sporolactobacillus laevolacticus Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 240000000785 Tagetes erecta Species 0.000 description 2
- 108010083809 Talin Proteins 0.000 description 2
- 102000006463 Talin Human genes 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 244000185386 Thladiantha grosvenorii Species 0.000 description 2
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 244000089698 Zanthoxylum simulans Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 108010055615 Zein Proteins 0.000 description 2
- 229920002494 Zein Polymers 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960003558 almasilate Drugs 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000001670 anatto Substances 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 230000001967 antemetic effect Effects 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000003208 anti-thyroid effect Effects 0.000 description 2
- 239000000924 antiasthmatic agent Substances 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940125681 anticonvulsant agent Drugs 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229940043671 antithyroid preparations Drugs 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- 235000012733 azorubine Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000012677 beetroot red Nutrition 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 235000012709 brilliant black BN Nutrition 0.000 description 2
- ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 2
- 229960000725 brompheniramine Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004075 cariostatic agent Substances 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 2
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 2
- 229940099898 chlorophyllin Drugs 0.000 description 2
- 235000019805 chlorophyllin Nutrition 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000008373 coffee flavor Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019244 cryptoxanthin Nutrition 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 229950009125 cynarine Drugs 0.000 description 2
- YDDUMTOHNYZQPO-BKUKFAEQSA-N cynarine Natural products O[C@H]1C[C@@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-BKUKFAEQSA-N 0.000 description 2
- 229940022769 d- lactic acid Drugs 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- PIEXSEDEFNIKCT-UHFFFAOYSA-N dialuminum magnesium dioxido(oxo)silane hydrate Chemical compound O.[Mg++].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PIEXSEDEFNIKCT-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- ICFXZZFWRWNZMA-UHFFFAOYSA-N diethylpropion hydrochloride Chemical compound [Cl-].CC[NH+](CC)C(C)C(=O)C1=CC=CC=C1 ICFXZZFWRWNZMA-UHFFFAOYSA-N 0.000 description 2
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 description 2
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 description 2
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 2
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 2
- 238000006471 dimerization reaction Methods 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000014134 echinacea Nutrition 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 239000004174 erythrosine Substances 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 229940073505 ethyl vanillin Drugs 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000019243 flavoxanthin Nutrition 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- 238000003682 fluorination reaction Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 235000012701 green S Nutrition 0.000 description 2
- 239000004120 green S Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- BPMFZUMJYQTVII-UHFFFAOYSA-N guanidinoacetic acid Chemical compound NC(=N)NCC(O)=O BPMFZUMJYQTVII-UHFFFAOYSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000019314 gum ghatti Nutrition 0.000 description 2
- 229930183009 gymnemic acid Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 235000012738 indigotine Nutrition 0.000 description 2
- 239000004179 indigotine Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 229960003088 loratadine Drugs 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000001115 mace Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 235000012254 magnesium hydroxide Nutrition 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- 238000010077 mastication Methods 0.000 description 2
- 239000001683 mentha spicata herb oil Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229940066491 mucolytics Drugs 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 235000012658 paprika extract Nutrition 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 239000007967 peppermint flavor Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 229940093625 propylene glycol monostearate Drugs 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000019246 rhodoxanthin Nutrition 0.000 description 2
- 235000009514 rubixanthin Nutrition 0.000 description 2
- 239000000455 rubixanthin Substances 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 235000019721 spearmint oil Nutrition 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 239000008371 vanilla flavor Substances 0.000 description 2
- 239000012178 vegetable wax Substances 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- 239000003190 viscoelastic substance Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- AAWZDTNXLSGCEK-WYWMIBKRSA-N (-)-quinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1O AAWZDTNXLSGCEK-WYWMIBKRSA-N 0.000 description 1
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- UQXZSKHOYOHVIH-UGDNZRGBSA-N (2R,3R,4S,5S,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 UQXZSKHOYOHVIH-UGDNZRGBSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- DAXJNUBSBFUTRP-RTQNCGMRSA-N (8r,9s,10r,13s,14s)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(CO)C2=C1 DAXJNUBSBFUTRP-RTQNCGMRSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- ULDHMXUKGWMISQ-VIFPVBQESA-N (S)-(+)-Carvone Natural products CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 1
- WXUAQHNMJWJLTG-VKHMYHEASA-N (S)-methylsuccinic acid Chemical compound OC(=O)[C@@H](C)CC(O)=O WXUAQHNMJWJLTG-VKHMYHEASA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- CHLICZRVGGXEOD-UHFFFAOYSA-N 1-Methoxy-4-methylbenzene Chemical compound COC1=CC=C(C)C=C1 CHLICZRVGGXEOD-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical compound O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 description 1
- CBOBADCVMLMQRW-UHFFFAOYSA-N 2,6-dimethyloctanal Chemical group CCC(C)CCCC(C)C=O CBOBADCVMLMQRW-UHFFFAOYSA-N 0.000 description 1
- LOVYCUYJRWLTSU-UHFFFAOYSA-N 2-(3,4-dichlorophenoxy)-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=C(Cl)C(Cl)=C1 LOVYCUYJRWLTSU-UHFFFAOYSA-N 0.000 description 1
- KGSVNOLLROCJQM-UHFFFAOYSA-N 2-(benzylamino)acetic acid Chemical compound OC(=O)CNCC1=CC=CC=C1 KGSVNOLLROCJQM-UHFFFAOYSA-N 0.000 description 1
- UNNGUFMVYQJGTD-UHFFFAOYSA-N 2-Ethylbutanal Chemical class CCC(CC)C=O UNNGUFMVYQJGTD-UHFFFAOYSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- MCNJOIMMYWLFBA-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)CS(O)(=O)=O MCNJOIMMYWLFBA-UHFFFAOYSA-N 0.000 description 1
- RMGHERXMTMUMMV-UHFFFAOYSA-N 2-methoxypropane Chemical group COC(C)C RMGHERXMTMUMMV-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- MPPQGYCZBNURDG-UHFFFAOYSA-N 2-propionyl-6-dimethylaminonaphthalene Chemical compound C1=C(N(C)C)C=CC2=CC(C(=O)CC)=CC=C21 MPPQGYCZBNURDG-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BRRVXFOKWJKTGG-UHFFFAOYSA-N 3,3,5-trimethylcyclohexanol Chemical compound CC1CC(O)CC(C)(C)C1 BRRVXFOKWJKTGG-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- VZRRCQOUNSHSGB-UHFFFAOYSA-N 4-hydroxy-4,6,6-trimethylbicyclo[3.1.1]heptan-3-one Chemical compound C1C2C(C)(C)C1CC(=O)C2(O)C VZRRCQOUNSHSGB-UHFFFAOYSA-N 0.000 description 1
- DCTLYFZHFGENCW-UUOKFMHZSA-N 5'-xanthylic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 DCTLYFZHFGENCW-UUOKFMHZSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- NFLLKCVHYJRNRH-UHFFFAOYSA-N 8-chloro-1,3-dimethyl-7H-purine-2,6-dione 2-(diphenylmethyl)oxy-N,N-dimethylethanamine Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(Cl)=N2.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 NFLLKCVHYJRNRH-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 244000145321 Acmella oleracea Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000011470 Adenanthera pavonina Nutrition 0.000 description 1
- 240000001606 Adenanthera pavonina Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 240000000662 Anethum graveolens Species 0.000 description 1
- 235000011514 Anogeissus latifolia Nutrition 0.000 description 1
- 244000106483 Anogeissus latifolia Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- DCFGGGCMICWSJX-SNAWJCMRSA-N Butyl oleate sulfate Chemical compound CCCCOC(=O)CCCCCCC\C=C\CCCCCCCCOS(O)(=O)=O DCFGGGCMICWSJX-SNAWJCMRSA-N 0.000 description 1
- RTMBGDBBDQKNNZ-UHFFFAOYSA-L C.I. Acid Blue 3 Chemical compound [Ca+2].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1.C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 RTMBGDBBDQKNNZ-UHFFFAOYSA-L 0.000 description 1
- NCVQVCRIORLULH-UHFFFAOYSA-N CC1=CCC(C=C1C(=O)O)C(=O)O Chemical class CC1=CCC(C=C1C(=O)O)C(=O)O NCVQVCRIORLULH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 244000284152 Carapichea ipecacuanha Species 0.000 description 1
- AKJDEXBCRLOVTH-UHFFFAOYSA-N Carbetapentane citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C1(C(=O)OCCOCCN(CC)CC)CCCC1 AKJDEXBCRLOVTH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000218646 Cedrus deodara Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- XYGSFNHCFFAJPO-UHFFFAOYSA-N Chlophedianol hydrochloride Chemical compound Cl.C=1C=CC=C(Cl)C=1C(O)(CCN(C)C)C1=CC=CC=C1 XYGSFNHCFFAJPO-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000305791 Commidendrum rugosum Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 125000003535 D-glucopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000012848 Dextrorphan Substances 0.000 description 1
- TUSIZTVSUSBSQI-UHFFFAOYSA-N Dihydrocarveol acetate Chemical compound CC1CCC(C(C)=C)CC1OC(C)=O TUSIZTVSUSBSQI-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 240000004530 Echinacea purpurea Species 0.000 description 1
- 241000044408 Eriochloa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001336 FEMA 3807 Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 239000001922 Gum ghatti Substances 0.000 description 1
- 241000168517 Haematococcus lacustris Species 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 235000008418 Hedeoma Nutrition 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241001504226 Hoodia Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000013038 Hypocalcemia Diseases 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- 235000003325 Ilex Nutrition 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 239000009471 Ipecac Substances 0.000 description 1
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical compound CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241001561398 Lactobacillus jensenii Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 240000002636 Manilkara bidentata Species 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- OCJYIGYOJCODJL-UHFFFAOYSA-N Meclizine Chemical compound CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 OCJYIGYOJCODJL-UHFFFAOYSA-N 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- 240000007707 Mentha arvensis Species 0.000 description 1
- 235000018978 Mentha arvensis Nutrition 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- ZBJCYZPANVLBRK-UHFFFAOYSA-N Menthone 1,2-glyceryl ketal Chemical compound CC(C)C1CCC(C)CC11OC(CO)CO1 ZBJCYZPANVLBRK-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101710084933 Miraculin Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- YSEXMKHXIOCEJA-FVFQAYNVSA-N Nicergoline Chemical compound C([C@@H]1C[C@]2([C@H](N(C)C1)CC=1C3=C2C=CC=C3N(C)C=1)OC)OC(=O)C1=CN=CC(Br)=C1 YSEXMKHXIOCEJA-FVFQAYNVSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 description 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001495453 Parthenium argentatum Species 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000002770 Petroselinum crispum Nutrition 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- MFOCDFTXLCYLKU-CMPLNLGQSA-N Phendimetrazine Chemical compound O1CCN(C)[C@@H](C)[C@@H]1C1=CC=CC=C1 MFOCDFTXLCYLKU-CMPLNLGQSA-N 0.000 description 1
- ISFHAYSTHMVOJR-UHFFFAOYSA-N Phenindamine Chemical compound C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 ISFHAYSTHMVOJR-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 201000010273 Porphyria Cutanea Tarda Diseases 0.000 description 1
- 235000016551 Potentilla erecta Nutrition 0.000 description 1
- 240000000103 Potentilla erecta Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- PSIOOHPZLJTGJH-UHFFFAOYSA-M S(=O)(=O)([O-])[O-].[NH4+].[Zn+] Chemical compound S(=O)(=O)([O-])[O-].[NH4+].[Zn+] PSIOOHPZLJTGJH-UHFFFAOYSA-M 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- 240000000203 Salix gracilistyla Species 0.000 description 1
- 244000143590 Salvia chinensis Species 0.000 description 1
- 235000007154 Salvia chinensis Nutrition 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000220287 Sedum rubrotinctum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 235000009932 Zanthoxylum simulans Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- UJNOLBSYLSYIBM-SGUBAKSOSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] 2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C(C)O UJNOLBSYLSYIBM-SGUBAKSOSA-N 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- MNCUCCJMXIWMJJ-OWOJBTEDSA-N [(e)-2-thiocyanatoethenyl] thiocyanate Chemical compound N#CS\C=C\SC#N MNCUCCJMXIWMJJ-OWOJBTEDSA-N 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- YJVBLROMQZEFPA-UHFFFAOYSA-L acid red 26 Chemical compound [Na+].[Na+].CC1=CC(C)=CC=C1N=NC1=C(O)C(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=CC=C12 YJVBLROMQZEFPA-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229960003792 acrivastine Drugs 0.000 description 1
- PWACSDKDOHSSQD-IUTFFREVSA-N acrivastine Chemical compound C1=CC(C)=CC=C1C(\C=1N=C(\C=C\C(O)=O)C=CC=1)=C/CN1CCCC1 PWACSDKDOHSSQD-IUTFFREVSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- QQQCWVDPMPFUGF-ZDUSSCGKSA-N alpinetin Chemical compound C1([C@H]2OC=3C=C(O)C=C(C=3C(=O)C2)OC)=CC=CC=C1 QQQCWVDPMPFUGF-ZDUSSCGKSA-N 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 159000000013 aluminium salts Chemical class 0.000 description 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940009859 aluminum phosphate Drugs 0.000 description 1
- JIFPTBLGXRKRAO-UHFFFAOYSA-K aluminum;magnesium;hydroxide;sulfate Chemical compound [OH-].[Mg+2].[Al+3].[O-]S([O-])(=O)=O JIFPTBLGXRKRAO-UHFFFAOYSA-K 0.000 description 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 description 1
- 229960005174 ambroxol Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004004 anti-anginal agent Substances 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000648 anti-parkinson Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000320 anti-stroke effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940125684 antimigraine agent Drugs 0.000 description 1
- 239000002282 antimigraine agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 229960000383 azatadine Drugs 0.000 description 1
- SEBMTIQKRHYNIT-UHFFFAOYSA-N azatadine Chemical compound C1CN(C)CCC1=C1C2=NC=CC=C2CCC2=CC=CC=C21 SEBMTIQKRHYNIT-UHFFFAOYSA-N 0.000 description 1
- AIPVTTKYSPOWFO-UHFFFAOYSA-N azepane-1-carbaldehyde Chemical compound O=CN1CCCCCC1 AIPVTTKYSPOWFO-UHFFFAOYSA-N 0.000 description 1
- 239000004176 azorubin Substances 0.000 description 1
- TVWOWDDBXAFQDG-DQRAZIAOSA-N azorubine Chemical compound C1=CC=C2C(\N=N/C3=C(C4=CC=CC=C4C(=C3)S(O)(=O)=O)O)=CC=C(S(O)(=O)=O)C2=C1 TVWOWDDBXAFQDG-DQRAZIAOSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000016302 balata Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YNKMHABLMGIIFX-UHFFFAOYSA-N benzaldehyde;methane Chemical compound C.O=CC1=CC=CC=C1 YNKMHABLMGIIFX-UHFFFAOYSA-N 0.000 description 1
- 229940076134 benzene Drugs 0.000 description 1
- MAFMQEKGGFWBAB-UHFFFAOYSA-N benzonatate Chemical compound CCCCNC1=CC=C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C=C1 MAFMQEKGGFWBAB-UHFFFAOYSA-N 0.000 description 1
- 229960003789 benzonatate Drugs 0.000 description 1
- YXKTVDFXDRQTKV-HNNXBMFYSA-N benzphetamine Chemical compound C([C@H](C)N(C)CC=1C=CC=CC=1)C1=CC=CC=C1 YXKTVDFXDRQTKV-HNNXBMFYSA-N 0.000 description 1
- 229960002837 benzphetamine Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 239000011774 beta-cryptoxanthin Substances 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- YZXZAUAIVAZWFN-UHFFFAOYSA-N bis(5-methyl-2-propan-2-ylcyclohexyl) butanedioate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(=O)OC1C(C(C)C)CCC(C)C1 YZXZAUAIVAZWFN-UHFFFAOYSA-N 0.000 description 1
- 229940104825 bismuth aluminate Drugs 0.000 description 1
- 229940036348 bismuth carbonate Drugs 0.000 description 1
- 229960000199 bismuth subgallate Drugs 0.000 description 1
- XXCBNHDMGIZPQF-UHFFFAOYSA-L bismuth(2+);5-carboxy-3-hydroxybenzene-1,2-diolate;hydrate Chemical compound O.OC1=CC(C(=O)O)=CC2=C1O[Bi]O2 XXCBNHDMGIZPQF-UHFFFAOYSA-L 0.000 description 1
- 235000002333 black apple Nutrition 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000013532 brandy Nutrition 0.000 description 1
- 239000004126 brilliant black BN Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229940074995 bromine Drugs 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- NNOYLBKZPCUCQT-UHFFFAOYSA-L calcium;1,1-dioxo-1,2-benzothiazol-3-olate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Ca+2].C1=CC=C2C([O-])=NS(=O)(=O)C2=C1.C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 NNOYLBKZPCUCQT-UHFFFAOYSA-L 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- VYIRVAXUEZSDNC-RDJLEWNRSA-N capsanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-RDJLEWNRSA-N 0.000 description 1
- 239000001325 capsicum annuum l. var. longum oleoresin Substances 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- JYNBEDVXQNFTOX-UHFFFAOYSA-N chembl2008134 Chemical compound OS(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C(O)=O)=CC2=CC=CC=C12 JYNBEDVXQNFTOX-UHFFFAOYSA-N 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940020114 chlophedianol hydrochloride Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012698 chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011538 cleaning material Substances 0.000 description 1
- 229960002881 clemastine Drugs 0.000 description 1
- YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 description 1
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 239000001081 curcuma longa l. root oleoresin Substances 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 1
- 229960001140 cyproheptadine Drugs 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 1
- JAQUASYNZVUNQP-PVAVHDDUSA-N dextrorphan Chemical compound C1C2=CC=C(O)C=C2[C@@]23CCN(C)[C@@H]1[C@H]2CCCC3 JAQUASYNZVUNQP-PVAVHDDUSA-N 0.000 description 1
- 229950006878 dextrorphan Drugs 0.000 description 1
- GMZOPRQQINFLPQ-UHFFFAOYSA-H dibismuth;tricarbonate Chemical compound [Bi+3].[Bi+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O GMZOPRQQINFLPQ-UHFFFAOYSA-H 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- XXEPPPIWZFICOJ-UHFFFAOYSA-N diethylpropion Chemical compound CCN(CC)C(C)C(=O)C1=CC=CC=C1 XXEPPPIWZFICOJ-UHFFFAOYSA-N 0.000 description 1
- 229960004890 diethylpropion Drugs 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 1
- RBNPZEHAODHBPZ-UHFFFAOYSA-M dihydroxyaluminium Chemical compound O.O.NCC(=O)O[Al] RBNPZEHAODHBPZ-UHFFFAOYSA-M 0.000 description 1
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960001583 diphenhydramine citrate Drugs 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- RMGVZKRVHHSUIM-UHFFFAOYSA-N dithionic acid Chemical compound OS(=O)(=O)S(O)(=O)=O RMGVZKRVHHSUIM-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- 229940099182 dramamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960000385 dyclonine Drugs 0.000 description 1
- BZEWSEKUUPWQDQ-UHFFFAOYSA-N dyclonine Chemical compound C1=CC(OCCCC)=CC=C1C(=O)CCN1CCCCC1 BZEWSEKUUPWQDQ-UHFFFAOYSA-N 0.000 description 1
- KNZADIMHVBBPOA-UHFFFAOYSA-N dyclonine hydrochloride Chemical compound [Cl-].C1=CC(OCCCC)=CC=C1C(=O)CC[NH+]1CCCCC1 KNZADIMHVBBPOA-UHFFFAOYSA-N 0.000 description 1
- 229960003462 dyclonine hydrochloride Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229960001971 ebastine Drugs 0.000 description 1
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 1
- ZQHFZHPUZXNPMF-UHFFFAOYSA-N ebrotidine Chemical compound S1C(N=C(N)N)=NC(CSCCN=CNS(=O)(=O)C=2C=CC(Br)=CC=2)=C1 ZQHFZHPUZXNPMF-UHFFFAOYSA-N 0.000 description 1
- 229950002377 ebrotidine Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- PLYDMIIYRWUYBP-UHFFFAOYSA-N ethyl 4-[[2-chloro-4-[3-chloro-4-[(3-ethoxycarbonyl-5-oxo-1-phenyl-4h-pyrazol-4-yl)diazenyl]phenyl]phenyl]diazenyl]-5-oxo-1-phenyl-4h-pyrazole-3-carboxylate Chemical compound CCOC(=O)C1=NN(C=2C=CC=CC=2)C(=O)C1N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(=N1)C(=O)OCC)C(=O)N1C1=CC=CC=C1 PLYDMIIYRWUYBP-UHFFFAOYSA-N 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000012656 ethyl ester of beta-apo-8'-carotenic acid Nutrition 0.000 description 1
- 239000001684 ethyl ester of beta-apo-8'-carotenic acid (C30) Substances 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 229960003592 fexofenadine Drugs 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003939 flavanonol Natural products 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 150000002221 fluorine Chemical class 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182479 fructoside Natural products 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010193 gold Nutrition 0.000 description 1
- 239000004333 gold (food color) Substances 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- WDPIZEKLJKBSOZ-UHFFFAOYSA-M green s Chemical compound [Na+].C1=CC(N(C)C)=CC=C1C(C=1C2=CC=C(C=C2C=C(C=1O)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](C)C)C=C1 WDPIZEKLJKBSOZ-UHFFFAOYSA-M 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000019668 heartiness Nutrition 0.000 description 1
- PDSAKIXGSONUIX-UHFFFAOYSA-N hexaaluminum;dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Bi+3].[Bi+3] PDSAKIXGSONUIX-UHFFFAOYSA-N 0.000 description 1
- TVHALOSDPLTTSR-UHFFFAOYSA-H hexasodium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O TVHALOSDPLTTSR-UHFFFAOYSA-H 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 239000002788 histamine agent Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000017277 hoodia Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
- 229960000240 hydrocodone Drugs 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000000705 hypocalcaemia Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940029408 ipecac Drugs 0.000 description 1
- 239000004407 iron oxides and hydroxides Substances 0.000 description 1
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 229960004018 magaldrate Drugs 0.000 description 1
- 229960001708 magnesium carbonate Drugs 0.000 description 1
- 229940004916 magnesium glycinate Drugs 0.000 description 1
- 229960000816 magnesium hydroxide Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- AACACXATQSKRQG-UHFFFAOYSA-L magnesium;2-aminoacetate Chemical compound [Mg+2].NCC([O-])=O.NCC([O-])=O AACACXATQSKRQG-UHFFFAOYSA-L 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960001474 meclozine Drugs 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- BHQQXAOBIZQEGI-UHFFFAOYSA-N methyl 2-chlorobutanoate Chemical compound CCC(Cl)C(=O)OC BHQQXAOBIZQEGI-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 229950008866 mifentidine Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000019575 mouthfulness Nutrition 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOZUADYOHPCXLE-UHFFFAOYSA-N n-[4-(1h-imidazol-5-yl)phenyl]-n'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=CN1 GOZUADYOHPCXLE-UHFFFAOYSA-N 0.000 description 1
- 229960004270 nabumetone Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CDBRNDSHEYLDJV-FVGYRXGTSA-M naproxen sodium Chemical compound [Na+].C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CDBRNDSHEYLDJV-FVGYRXGTSA-M 0.000 description 1
- 229960003940 naproxen sodium Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 229940105623 neo-synephrine Drugs 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 229960003642 nicergoline Drugs 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- XRRQZKOZJFDXON-UHFFFAOYSA-N nitric acid;silver Chemical compound [Ag].O[N+]([O-])=O XRRQZKOZJFDXON-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 125000003431 oxalo group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960002085 oxycodone Drugs 0.000 description 1
- 229960001528 oxymetazoline Drugs 0.000 description 1
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 108700009886 palmitoyl sarcosine Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- DYUUPIKEWLHQGQ-SDXBLLFJSA-N paprika oleoresin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-SDXBLLFJSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 230000001499 parasympathomimetic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- QGWDKKHSDXWPET-UHFFFAOYSA-E pentabismuth;oxygen(2-);nonahydroxide;tetranitrate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O-2].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QGWDKKHSDXWPET-UHFFFAOYSA-E 0.000 description 1
- 229960003436 pentoxyverine Drugs 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 229960000436 phendimetrazine Drugs 0.000 description 1
- 229940107333 phenergan Drugs 0.000 description 1
- 229960003534 phenindamine Drugs 0.000 description 1
- 229960003562 phentermine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- XMGMFRIEKMMMSU-UHFFFAOYSA-N phenylmethylbenzene Chemical group C=1C=CC=CC=1[C]C1=CC=CC=C1 XMGMFRIEKMMMSU-UHFFFAOYSA-N 0.000 description 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 description 1
- 229960001526 phenyltoloxamine Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- NUSQOFAKCBLANB-UHFFFAOYSA-N phthalocyanine tetrasulfonic acid Chemical compound C12=CC(S(=O)(=O)O)=CC=C2C(N=C2NC(C3=CC=C(C=C32)S(O)(=O)=O)=N2)=NC1=NC([C]1C=CC(=CC1=1)S(O)(=O)=O)=NC=1N=C1[C]3C=CC(S(O)(=O)=O)=CC3=C2N1 NUSQOFAKCBLANB-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- PZTQVMXMKVTIRC-RZLHGTIFSA-L pigment rubine Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1\N=N\C1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-RZLHGTIFSA-L 0.000 description 1
- 239000001894 piper nigrum l. oleoresin black Substances 0.000 description 1
- 229940081310 piperonal Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 229940124837 pisatidine Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 235000012731 ponceau 4R Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- HQEROMHPIOLGCB-DFWYDOINSA-M potassium;(2s)-2-aminopentanedioate;hydron Chemical compound [K+].[O-]C(=O)[C@@H](N)CCC(O)=O HQEROMHPIOLGCB-DFWYDOINSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000395 remineralizing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229960003320 roxatidine Drugs 0.000 description 1
- 229960003287 roxatidine acetate Drugs 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940043243 saccharin calcium Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000019940 salatrim Nutrition 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- 229960002639 sildenafil citrate Drugs 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229960001516 silver nitrate Drugs 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- IJRHDFLHUATAOS-DPMBMXLASA-M sodium ricinoleate Chemical compound [Na+].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O IJRHDFLHUATAOS-DPMBMXLASA-M 0.000 description 1
- 229940079864 sodium stannate Drugs 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical compound OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 1
- 229940032330 sulfuric acid Drugs 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 235000013759 synthetic iron oxide Nutrition 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 229940034887 tenuate Drugs 0.000 description 1
- 229940103784 tepanil Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229960003223 tripelennamine Drugs 0.000 description 1
- CBEQULMOCCWAQT-WOJGMQOQSA-N triprolidine Chemical compound C1=CC(C)=CC=C1C(\C=1N=CC=CC=1)=C/CN1CCCC1 CBEQULMOCCWAQT-WOJGMQOQSA-N 0.000 description 1
- 229960001128 triprolidine Drugs 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013975 turmeric oleoresin Nutrition 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- KOCVACNWDMSLBM-UHFFFAOYSA-N vanillyl alcohol ethyl ether Natural products CCOCC1=CC=C(O)C(OC)=C1 KOCVACNWDMSLBM-UHFFFAOYSA-N 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229940074158 xanax Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- SRWMQSFFRFWREA-UHFFFAOYSA-M zinc formate Chemical compound [Zn+2].[O-]C=O SRWMQSFFRFWREA-UHFFFAOYSA-M 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
- XLMCDAMBOROREP-UHFFFAOYSA-N zinc;3-phosphonooxypropane-1,2-diolate Chemical compound [Zn+2].OP(O)(=O)OCC([O-])C[O-] XLMCDAMBOROREP-UHFFFAOYSA-N 0.000 description 1
- AGFGXVAAIXIOFZ-UHFFFAOYSA-L zinc;butanedioate Chemical compound [Zn+2].[O-]C(=O)CCC([O-])=O AGFGXVAAIXIOFZ-UHFFFAOYSA-L 0.000 description 1
- NDKWCCLKSWNDBG-UHFFFAOYSA-N zinc;dioxido(dioxo)chromium Chemical compound [Zn+2].[O-][Cr]([O-])(=O)=O NDKWCCLKSWNDBG-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Confectionery (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
本发明公开了一种形成具有起伏的咀嚼型胶基糖产品的方法,所述方法包括:提供包括至少一个辊的胶基糖定型系统;使胶基糖料团沿着料流方向朝向所述定型系统移动并通过所述定型系统;经由所述定型系统将所述胶基糖料团定型为基本上连续的胶基糖片材,所述胶基糖片材经由所述定型而在所述胶基糖片材的至少一部分具有在约0.3mm至10mm之间的厚度;经由所述定型系统的所述至少一个辊在所述胶基糖片材中创建厚度变化,其中所述厚度变化的所述创建步骤和所述将所述胶基糖料团定型为所述胶基糖片材的步骤基本上同时发生;并且将所述胶基糖片材分离成多个胶基糖块,所述多个块中的至少一个包括所述厚度变化。
Description
本申请是2013年9月19日递交的PCT国际申请PCT/US2013/060584于2015年3 月5日进入中国国家阶段的中国专利申请号为201380046385.9、发明名称为“先进的胶基 糖形成”的发明专利申请的分案申请。
技术领域
本发明涉及胶基糖制造方法和系统,更具体地讲,涉及胶基糖形成系统和方法。
背景技术
典型地,制作和包装胶基糖产品的方法很花时间且涉及大量机械。制作和包装胶基糖 产品的方法可包括混合和生产成品胶基糖、将所述成品胶基糖挤出和形成为条块、调理所 述成品胶基糖的所述条块、将所述条块挤出成所述成品胶基糖的连续薄片材、将所述连续 片材辗过一连串的辊成为均匀的减少的厚度、将片材进行刻划和分成各单个刻划片材、在 调理室调理所述各单个片材、将片材划分成胶基糖块以及包装所述胶基糖块。这样的制作 和包装胶基糖产品的方法在被转让给本受让人的原权益人的美国专利第6,254,373号和被 转让给本受让人的美国专利申请第12/352,110号中被公开;所述专利和专利申请的教导和 公开内容,只要不与本公开相矛盾,则以引用方式整体并入本文。
传统的定型(sizing)机械可包括定型挤出机,所述定型挤出机迫使咀嚼型胶基糖通过小 的矩形的孔口(例如,具有约25mm×457mm的尺寸的矩形孔口)。随着孔口大小变小,需要相对而言相当大的力(例如,为了足够的输出/生产量,可能需要30马力(HP)的驱动力)。典型地,离开所述定型挤出机的产品仍然太厚。因此,许多现有系统典型地会采用 一连串的在传送带之上顺次排列的定型辊,来将胶基糖的厚度从大约25mm逐步减少至典 型的约2-6mm。为了防止胶基糖粘连到辊,典型地采取撒以合适的粉末剂。其后,可使用 刻划滚筒和划分滚筒来产生薄的条,或稍短且更厚的胶基糖厚片,或丸(前述的条、厚片、 丸或其它尺寸的胶基糖中的任一者可被称为“定型的胶基糖”)。这样的传统生产线还典型 地会使得需要后续进行一定量的冷却和/或调理,然后进行包装,因为温热的柔软产品不 能很好地进行包装。
除了要关注定型之外,要将起伏(contour)和通道形成到胶基糖表面中会具有挑战性, 并且需要许多额外的加工步骤。事实上,在某些加工方向上形成起伏可能非常难以经由传 统的挤出方法创建,即使这种创建是有可能的。
本发明涉及对此类现有胶基糖产品制作和包装的系统和方法的改进和发展。
发明内容
本发明公开了一种形成具有起伏的咀嚼型胶基糖产品的方法,所述方法包括:提供包 括至少一个辊的胶基糖定型系统;使胶基糖料团沿着料流方向朝向所述定型系统移动并通 过所述定型系统;经由所述定型系统将所述胶基糖料团定型为基本上连续的胶基糖片材, 所述胶基糖片材经由所述定型步骤而在所述胶基糖片材的至少一部分具有在约0.3mm至 10mm之间的厚度;经由所述定型系统的所述至少一个辊在所述胶基糖片材中创建厚度变 化,其中所述厚度变化的所述创建步骤和所述将所述胶基糖料团定型为所述胶基糖片材的 步骤基本上同时发生;并且将所述胶基糖片材分离成多个胶基糖块,所述多个块中的至少 一个包括所述厚度变化。
在一些实施方案中,所述厚度变化在基本上垂直于所述料流的所述方向上发生。在一 些实施方案中,所述至少一个辊包括在所述料流方向上围绕所述至少一个第一辊的圆周的 至少一个直径变化,所述至少一个直径变化在所述胶基糖料团中赋予所述厚度变化。在一 些实施方案中,所述定型系统是第一辊和第二辊,在所述第一辊和所述第二辊之间有一间 隙,其中所述第一辊和所述第二辊将穿过所述间隙的所述胶基糖料团定型为包括所述厚度 变化的所述胶基糖片材。在一些实施方案中,所述第一辊被设置于所述第二辊的相对上方, 所述第一辊包括在所述料流方向上围绕所述第一辊的圆周的至少一个直径变化,所述至少 一个直径变化在所述胶基糖料团的相对上表面中赋予所述厚度变化。在一些实施方案中, 所述第一辊被设置于所述第二辊的相对上方,所述第二辊包括在所述料流方向上围绕所述 第二辊的圆周的至少一个变化,所述至少一个直径变化在所述胶基糖料团的相对下表面中 赋予所述厚度变化。在一些实施方案中,所述第一辊被设置于所述第二辊的相对上方,所 述第一辊和所述第二辊各自包括在所述料流方向上围绕所述第一辊和所述第二辊的圆周 的至少一个直径变化,所述第一辊和所述第二辊中的所述至少一个直径变化在所述胶基糖 料团的对向的上表面和下表面中赋予所述厚度变化。在一些实施方案中,所述厚度变化的 至少一个情形是跨所述胶基糖片材的基本上整个长度和基本上整个宽度的至少一者连续 的。在一些实施方案中,所述厚度变化的至少一个情形是跨所述胶基糖片材的长度和宽度 的至少一者不连续的。在一些实施方案中,所述方法还包括经由所述至少一个辊将所述胶 基糖片材冷却,并经由所述冷却步骤将所述厚度变化固化。在一些实施方案中,所述厚度 变化在所述料流的所述方向上发生。在一些实施方案中,所述至少一个辊包括跨所述至少 一个辊轴向延伸的至少一个变化,所述至少一个直径变化在所述胶基糖片材中赋予所述厚 度变化。在一些实施方案中,所述至少一个辊包括跨所述第一辊的表面轴向延伸的至少一 个直径变化,所述至少一个直径变化在所述咀嚼型胶基糖片材中赋予所述厚度变化。在一 些实施方案中,所述第一辊被设置于所述第二辊的相对上方,所述第一辊包括跨所述第一 辊的表面轴向延伸的至少一个直径变化,所述至少一个直径变化在所述咀嚼型胶基糖片材 的相对上表面中赋予所述厚度变化。在一些实施方案中,所述第一辊被设置于所述第二辊 的相对上方,所述第二辊包括跨所述第二辊的表面轴向延伸的至少一个变化,所述至少一 个直径变化在所述咀嚼型胶基糖片材的相对下表面中赋予所述厚度变化。在一些实施方案 中,所述第一辊被设置于所述第二辊的相对上方,所述第一辊和所述第二辊各自包括跨所 述第一辊和所述第二辊的表面轴向延伸的至少一个直径变化,所述第一辊和所述第二辊中 的所述至少一个直径变化在所述咀嚼型片材的对向的上表面和下表面中赋予所述厚度变 化。在一些实施方案中,所述厚度变化是所述胶基糖片材中的至少一个凹入部,所述方法 还包括用糖食组合物填充所述至少一个凹入部。在一些实施方案中,所述方法还包括经由 所述厚度变化在所述胶基糖片材中创建压纹。
本发明还公开了一种形成具有起伏的多层咀嚼型胶基糖产品的方法,所述方法包括: 提供包括至少一个辊的第一胶基糖形成系统;提供包括至少一个辊的第二胶基糖形成系 统;使第一胶基糖组合物朝向所述第一形成系统移动并通过所述第一形成系统;使第二胶 基糖组合物朝向所述第二形成系统移动并通过所述第二形成系统;经由所述第一形成系统 的所述至少一个辊在至少所述第一胶基糖组合物的至少一个形成的表面创建厚度变化;将 所述第一胶基糖组合物和所述第二胶基糖组合物堆叠,使得所述第一胶基糖组合物的所述 形成的表面与所述第二胶基糖组合物接触;经由所述堆叠步骤形成多层胶基糖组合物;经 由与所述第二胶基糖组合物接触的所述形成的表面中的至少所述厚度变化的存在,在所述 多层胶基糖组合物中创建至少一个空腔;并且将所述多层胶基糖组合物分离成多个胶基糖 块,所述多个块中的至少一个包括所述至少一个空腔。
在一些实施方案中,所述方法还包括经由所述第二形成系统的所述至少一个辊在所述 第二胶基糖组合物的至少一个形成的表面创建厚度变化,将所述第一胶基糖组合物和所述 第二胶基糖组合物堆叠,使得所述第一胶基糖组合物的所述形成的表面与所述第二胶基糖 组合物的所述形成的表面接触,并且经由所述第一咀嚼型胶基糖组合物的所述形成的表面 中的至少所述厚度变化和所述第二咀嚼型胶基糖组合物的所述形成的表面中的所述厚度 变化的存在,在所述多层胶基糖组合物中创建所述至少一个空腔。
在一些实施方案中,所述方法还包括经由所述第一形成系统将来自第一胶基糖料团的 所述第一胶基糖组合物定型为第一胶基糖片材,并经由所述第二形成系统将来自第二胶基 糖料团的所述第二胶基糖组合物定型为第二胶基糖片材,其中在所述第一胶基糖组合物的 所述至少一个形成的表面的所述厚度变化的所述创建步骤和在所述第二胶基糖组合物的 所述至少一个形成的表面的所述厚度变化的所述创建步骤,与所述将所述第一胶基糖料团 和所述第二胶基糖料团定型为所述第一胶基糖片材和所述第二胶基糖片材的步骤同时发 生。
在一些实施方案中,所述将所述第一胶基糖料团定型为所述第一胶基糖片材的步骤和 所述将所述第二胶基糖料团定型为所述第二胶基糖片材的步骤在所述第一胶基糖片材、所 述第二胶基糖片材和所述多层胶基糖组合物中的至少一者的至少一部分创建在约0.3mm 至10mm之间的厚度。
在一些实施方案中,所述方法还包括用另外的糖食组合物填充所述至少一个空腔。在 一些实施方案中,所述另外的糖食组合物是咀嚼型胶基糖组合物和糖食组合物中的至少一 者。在一些实施方案中,所述第一胶基糖形成系统和所述第二胶基糖形成系统彼此串联设 置。
本发明另外公开了一种形成咀嚼型胶基糖产品的方法,所述方法包括:提供包括至少 一个辊的胶基糖定型系统;使胶基糖料团沿着料流方向朝向所述定型系统移动并通过所述 定型系统;经由所述定型系统将所述胶基糖料团定型为基本上连续的胶基糖片材,所述胶 基糖片材经由所述定型步骤而在所述胶基糖片材的至少一部分具有在约0.3mm至10mm 之间的厚度;并且经由所述至少一个辊将所述胶基糖片材分离或基本上分离成多个胶基糖 块,所述分离或基本上分离的步骤与所述定型步骤基本上同时发生。
在一些实施方案中,所述多个胶基糖块中的每一个都被分离或基本上分离成符合期望 的形状。在一些实施方案中,所述基本上被分离的胶基糖块经由薄的卷材保持连接,所述 薄的卷材包括小于所述多个胶基糖块的厚度的30%的卷材厚度。在一些实施方案中,所述 方法还包括从所述薄的卷材分离所述胶基糖块。
本发明还公开了一种形成多层咀嚼型胶基糖产品的方法,所述方法包括:提供包括至 少一个辊的第一胶基糖形成系统;提供包括至少一个辊的第二胶基糖形成系统;使第一胶 基糖组合物朝向所述第一形成系统移动并通过所述第一形成系统;使第二胶基糖组合物朝 向所述第二形成系统移动并通过所述第二形成系统;经由所述至少一个辊从所述第一胶基 糖组合物基本上分离出多个第一胶基糖块,同时维持所述第一胶基糖块和所述第一胶基糖 组合物之间的第一卷材连接体(web connection);经由所述至少一个辊从所述第二胶基糖组 合物基本上分离出多个第二胶基糖块,同时维持所述第二胶基糖块和所述第二胶基糖组合 物之间的第二卷材连接体;将所述第一胶基糖块中的至少一个与所述第二胶基糖块中的至 少一个堆叠;并且经由所述堆叠步骤形成多层胶基糖组合物。
在一些实施方案中,所述多个第一胶基糖块中的每一个和所述多个第二胶基糖块中的 每一个都基本上被分离成符合期望的形状。在一些实施方案中,所述方法还包括将所述第 一胶基糖组合物的所述多个第一胶基糖块与所述第二胶基糖组合物的所述多个第二胶基 糖块对齐。在一些实施方案中,所述方法还包括将所述第一胶基糖块从所述第一卷材连接 体完全分离和将所述第二胶基糖块从所述第二卷材连接体完全分离,所述将与所述第二胶 基糖块对齐的所述第一胶基糖块完全分离的步骤产生呈现所述符合期望的形状的多层胶 基糖块。在一些实施方案中,所述方法还包括经由所述第一形成系统将来自第一胶基糖料 团的所述第一胶基糖组合物定型为第一胶基糖片材,并经由所述第二形成系统将来自第二 胶基糖料团的所述第二胶基糖组合物定型为第二胶基糖片材,其中所述将所述第一胶基糖 组合物分离或基本上分离为所述多个所述第一胶基糖块的步骤和所述将所述第二胶基糖 组合物分离或基本上分离为所述多个所述第二胶基糖块的步骤,与所述将所述第一胶基糖 料团和所述第二胶基糖料团定型成为所述第一胶基糖片材和所述第二胶基糖片材的步骤 同时发生。
本发明还公开了一种咀嚼型胶基糖块,所述咀嚼型胶基糖块处于适于包装的状态并根 据本发明所述的方法形成。
本发明还公开了一种多层咀嚼型胶基糖块,所述多层咀嚼型胶基糖块处于适于包装的 状态并根据本发明所述的方法形成。
本发明还公开了一种咀嚼型胶基糖块,所述咀嚼型胶基糖块处于适于包装的状态并根 据本发明所述的方法形成。
本发明还公开了一种多层咀嚼型胶基糖块,所述多层咀嚼型胶基糖块处于适于包装的 状态并根据本发明所述的方法形成。
附图说明
被并入专利说明书(specification)中并构成专利说明书的一部分的附图体现了本发明 的几个方面,并且附图连同实施方式(description)一起用以解释本发明的原理。在附图中:
图1是一种用于形成具有起伏的咀嚼型胶基糖的系统的示意图;
图1A是一种供在图1的系统中使用的示例性的辊的示意性正视图;
图1B是由图1A的辊所形成的胶基糖组合物的正视图;
图2A是一种供在图1的系统中使用的示例性的辊的示意性正视图;
图2B是由图2A的辊所形成的胶基糖组合物的正视图;
图3A是一种供在图1的系统中使用的示例性的辊的示意性正视图;
图3B是由图3A的辊所形成的胶基糖组合物的正视图;
图3C是由图3A的辊所形成的另一胶基糖组合物的正视图;
图4A是一种供在图1的系统中使用的示例性的辊的示意性立体图;
图4B是一种供在图1的系统中使用的示例性的辊的示意性立体图;
图5A是一种供在图1的系统中使用的示例性的辊的示意性立体图;
图5B是一种供在图1的系统中使用的示例性的辊的示意性立体图;
图6A是一种供在图1的系统中使用的示例性的辊的示意性立体图;
图6B是由图6A的辊所形成的胶基糖组合物的俯视图;
图7是另一种用于形成具有起伏的咀嚼型胶基糖的系统的示意图;
图7A-7D是由图7的系统所形成的各种胶基糖组合物实施例的正视图;
图8是图1和7中所示的系统的部分示意性正视图;
图9A是一种供在图1的系统中使用的示例性的辊的示意性立体图;
图9B是由图9A的辊所形成的胶基糖组合物的俯视图;
图10A是供在图1的系统中使用的示例性的辊的示意性立体图;
图10B是另一种供在图1的系统中使用的示例性的辊的示意性立体图;
图10C是由图10A的辊所形成的胶基糖组合物的俯视图;及
图10D是由图10B的辊所形成的胶基糖组合物的俯视图。
尽管将结合某些优选的实施例来描述本发明,但不欲将本发明限制于那些实施例。相 反,意欲涵盖被包括在由所附权利要求书限定的本发明的精神和范围内的所有替换、修改 和等同物。
具体实施方式
咀嚼型胶基糖概述
咀嚼型胶基糖在很大部分上包括不被吞咽的组分如胶基糖基料,胶基糖基料是橡胶样 的咀嚼组分。咀嚼型胶基糖还包含被消耗部分,所述被消耗部分包括甜味剂、风味物等, 并且咀嚼型胶基糖还可包括随其整合成层或作为成分随其整合的其它糖果或食品产品。胶 基糖基料在食品加工中是相对独特的,因为它给所述材料引入与加工有关的回弹性(resiliency)和弹性(elasticity),并且还提供传热不太好的相对非传导性材料或隔热材料。这 造成了独特的加工困难。与加工有关,被加工的胶基糖产品的温度很大程度地影响粘度以 及其它加工特征,如弹性和回弹性。
进一步地,不同类型的胶基糖配方也会改变加工的考虑因素,并且通常期望在相同的 设备或生产线上运行不同的胶基糖配方。所述成分中的一些能非常好地应对加工。其它成 分(如风味物)可能因热而散发掉,从而减少最终可消费产品中的风味物的量。其它成分 (如被包封的甜味剂)对剪切力(例如,由于大量的压力、强烈的混合、加工力等所致) 敏感,因此在加工期间会被损坏。这些因素均造成了与将所述胶基糖定型为一口咬的小份(small bit size portion)和为了在胶基糖包装中进行包装而调理所述胶基糖有关的不同的挑 战。为便于理解,将在下文讨论一些词语和典型的胶基糖组合物组分。
本文使用的“胶基糖结构”、“胶基糖料团”、“胶基糖片材”、“咀嚼型胶基糖”或“咀嚼型 胶基糖组合物”可包括但不限于从复合的弹性体到成品胶基糖的组合物(包括复合的弹性 体和成品胶基糖在内),所述组合物可包括复合的弹性体加上一些复合助剂、胶基糖基料 母料、复合的弹性体加上一些后续的胶基糖成分、复合的弹性体加上一些胶基糖基料成分 和一些后续的胶基糖成分、胶基糖基料、胶基糖基料加上一些后续的胶基糖成分、完成的 胶基糖母料以及成品胶基糖。
在解释根据本发明的系统和方法之前,讨论几种典型的咀嚼型胶基糖的一般组成是有 帮助的,所述典型的咀嚼型胶基糖在形成最复杂的咀嚼型胶基糖(即可使用本发明的系统 和方法的实施例来形成的成品胶基糖)时是被包括的或可以被包括。
本文使用的“成品胶基糖”指的是大体上准备好预备将产品分发给消费者的咀嚼型胶 基糖。故此,成品胶基糖可能仍需要进行温度调理、形成、成型、包装以及包衣。然而,所述胶基糖组合物本身是大体上完成的。并不是所有成品胶基糖均具有相同的成分或相同量的各个成分。此外,经由改变成分和成分的量,除了其它方面,可改变质构、风味物和 感觉等以提供不同的特性,从而满足使用者的需要。
众所周知,成品胶基糖通常包括水溶性的增量部分、水不溶性的胶基糖基料部分以及 一种或多种调味剂。水溶性部分在咀嚼过程中经一段时间消散。在整个咀嚼过程中,胶基 糖基料部分被保留在口中。成品胶基糖典型地是准备好供使用者消费的。
本文使用的“成品胶基糖基料”指的是包括胶基糖基料成分的足够的组合的咀嚼型胶 基糖,所述胶基糖基料成分仅需要与后续的胶基糖成分进行组合以形成成品胶基糖。成品 胶基糖基料是可咀嚼的粘弹性材料,所述粘弹性材料至少包括粘性组分、弹性组分以及软 化剂组分。例如,典型的胶基糖基料可包括弹性体,以及填充剂、树脂和/或增塑剂、聚乙酸乙烯酯和软化剂(如油、脂肪或蜡)中的至少一些。例如,未添加任何软化剂的仅仅 复合的弹性体不会是成品胶基糖基料,因为所述弹性体由于其难以咀嚼(如果不是不可能 咀嚼的话)而被认为不会是可用于成品咀嚼型胶基糖中的。
成分
咀嚼型胶基糖可包括分属各种类别的多种成分。根据本发明的各种实施例的胶基糖混 合系统和方法可用来混合任何和所有已知的成分,所述成分包括但不限于以下成分类别中 的成分:弹性体、增量剂、弹性体增塑剂(其包括树脂)、弹性体溶剂、增塑剂、脂肪、蜡、填充剂、抗氧化剂、甜味剂(例如增量甜味剂和高强度甜味剂)、糖浆/流体、风味 物、感知物(sensate)、增强剂、酸、乳化剂、色素、以及功能性成分。
不溶性胶基糖基料通常包括被归入以下类别中的成分:弹性体、弹性体增塑剂(树脂 或溶剂)、增塑剂、脂肪、油、蜡、软化剂以及填充剂。稍后将提供对每个类别内的代表 性成分的进一步讨论。胶基糖基料可占成品胶基糖的5至95重量%,更典型地占成品胶 基糖的10至50重量%,且最常见地占成品胶基糖的20至30重量%。
成品胶基糖的水溶性部分可包括被归入以下类别中的后续的胶基糖成分:软化剂、增 量甜味剂、高强度甜味剂、调味剂、酸、额外的填充剂、功能性成分及其组合。为了优化 胶基糖的可咀嚼性和口感,将软化剂添加到胶基糖。软化剂,也称塑化剂、增塑剂(plasticizing agent)或乳化剂,通常占咀嚼型胶基糖的0.5至15重量%。增量甜味剂占咀嚼 型胶基糖的5至95重量%,更典型地占所述胶基糖的20至80重量%,且最常见地占所述胶基糖的30至60重量%。高强度甜味剂也可存在,并且常见地与无糖甜味剂一起使用。 当使用高强度甜味剂时,其典型地占咀嚼型胶基糖的0.001至5重量%,优选地占咀嚼型 胶基糖的0.01至3重量%。典型地,高强度甜味剂比蔗糖甜至少20倍。
风味物通常应以在占咀嚼型胶基糖的约0.1至15重量%、优选地占所述胶基糖的约 0.2至5重量%、最优选地占所述胶基糖的约0.5至3重量%的范围内的量存在于胶基糖中。 可以使用天然的和人工的调味剂,并且以任何感觉上可接受的方式将其进行组合。
当包括酸时,其典型地占咀嚼型胶基糖的约0.001至5重量%。
可选的成分如色素、功能性成分以及额外的调味剂也可包括在咀嚼型胶基糖中。
以上提供了关于一般普通成分的较为概括的总述,以下将提供有关各个成分类别以及 各个类别中的具体成分的例子的更多细节。
弹性体
在咀嚼型胶基糖中采用的弹性体(橡胶)将取决于各种因素而变化很大,所述的因素 例如期望的咀嚼型胶基糖类型、期望的咀嚼型胶基糖稠度和在咀嚼型胶基糖中使用的其它 组分。所述弹性体可以是本领域已知的任何水不溶性聚合物,并且包括那些用于咀嚼型胶 基糖和吹泡型胶基糖的聚合物。适合的聚合物咀嚼型胶基糖,特别是胶基糖基料的说明性 例子包括天然和合成弹性体两者。例如,那些在咀嚼型胶基糖中适合的聚合物包括但不限 于(植物来源的)天然物质,如caspi、糖胶树胶、天然橡胶、冠胶、红檀木胶、山榄胶、节路顿胶、银菊胶、香豆树胶、尼日尔杜仲胶、卡斯德拉胶、巴拉塔树胶、杜仲胶、夹竹 桃科产胶树胶、香豆果胶、古塔胶等等,以及其组合。合成的弹性体的例子包括但不限于 苯乙烯-丁二烯共聚物(SBR)、聚异丁烯、异丁烯-异戊二烯共聚物、聚乙烯、聚乙酸乙烯酯 等等,以及其组合。弹性体占咀嚼型胶基糖的约10重量%至约60重量%,且更常见地占 咀嚼型胶基糖的约35重量%至约40重量%。
另外的可用的聚合物包括:交联聚乙烯吡咯烷酮、聚甲基丙烯酸甲酯;乳酸共聚物、 聚羟基烷酸酯、增塑乙基纤维素、聚乙酸乙烯邻苯二甲酸酯,以及其组合。
弹性体增塑剂
咀嚼型胶基糖可包含弹性体溶剂(在本文中也称为弹性体增塑剂)以帮助软化弹性体 材料。这样的弹性体溶剂可包括本领域已知的那些弹体性溶剂,例如,萜品烯树脂(如α- 蒎烯、β-蒎烯或右旋柠檬烯的聚合物),松香的甲酯、甘油酯和季戊四醇酯以及改性松香, 以及树胶如氢化的、二聚的和聚合的松香,及其混合物。适用于本文中的弹性体溶剂的例 子可包括部分氢化的木松香和脂松香的季戊四醇酯、木松香和脂松香的季戊四醇酯、木松 香的甘油酯、部分二聚的木松香和脂松香的甘油酯、聚合的木松香和脂松香的甘油酯、妥 尔油松香的甘油酯、木松香和脂松香的甘油酯及部分氢化的木松香和脂松香,木松香和脂 松香的部分氢化的甲酯等等,及其混合物。弹性体溶剂可以占咀嚼型胶基糖的约2重量% 至约15重量%、优选地约7重量%至约11重量%的量用于咀嚼型胶基糖中。
增塑剂
咀嚼型胶基糖还可包括增塑剂或软化剂(也被归入下文描述的蜡的类别)以提供各种 合乎期望的质构和稠度特性。由于这些成分的分子量低,增塑剂和软化剂能够透入咀嚼型 胶基糖的基础结构,使它成为可塑的且较不粘滞的。可用的增塑剂和软化剂包括三醋精、 中链的非氢化甘油三酯、部分氢化的棉籽油、大豆油、棕榈油、棕榈仁油、椰子油、红花油、动物油、可可脂、衍生自α-蒎烯的萜烯树脂、羊毛脂、棕榈酸、油酸、硬脂酸、硬脂 酸钠、硬脂酸钾、三乙酸甘油酯、甘油卵磷脂、单硬脂酸甘油酯、单硬脂酸丙二醇酯、乙 酰化单甘油乙酯、甘油等等,及其混合物。蜡也可加入咀嚼型胶基糖中,所述蜡例如天然 的和合成的蜡、氢化植物油、石油蜡如聚氨酯蜡、聚乙烯蜡、固体石蜡、脱水山梨糖醇单 硬脂酸酯、牛油、丙二醇及其混合物等等。增塑剂和软化剂通常以最高占咀嚼型胶基糖的 约20重量%的量、更具体地以占咀嚼型胶基糖的约9重量%至约17重量%的量用于咀嚼 型胶基糖中。
增塑剂还可包括可被单独采用或组合采用的氢化植物油、大豆油和棉籽油。这些增塑 剂为咀嚼型胶基糖提供良好的质构和柔软的咀嚼特性。这些增塑剂和软化剂通常以占咀嚼 型胶基糖的约5重量%至约14重量%的量、更具体地约5重量%至约13.5重量%的量采用。
脂肪
适合的油和脂肪包括部分氢化的植物脂肪或动物脂肪,如椰子油、棕榈仁油、牛脂以 及猪油等等。这些成分在使用时通常以最高占咀嚼型胶基糖的约7重量%、优选地最高约 3.5重量%的量存在。
蜡
在一些实施例中,咀嚼型胶基糖可包括蜡。所使用的蜡可包括合成的蜡和天然的蜡, 所述合成的蜡例如包含支链烷烃并且由单体共聚合的蜡(如但不限于聚丙烯和聚乙烯和 Fischer-Tropsch类型的蜡)、石油蜡(如石蜡)以及微晶蜡;所述天然的蜡例如蜂蜡、小烛树蜡、巴西棕榈蜡以及聚乙烯蜡、米糠和石油。
所述蜡软化聚合混合物并且改善咀嚼型胶基糖的弹性。所采用的蜡当存在时,将具有 约60℃以下的熔点,优选地具有在约45℃和约55℃之间的熔点。低熔点蜡可以是固体石 蜡。蜡可以占咀嚼型胶基糖的约6重量%至约10重量%的量、优选地约7重量%至约9.5重量%的量存在于咀嚼型胶基糖中。
除了低熔点蜡之外,具有较高熔点的蜡可以最高占咀嚼型胶基糖的约5重量%的量用 于咀嚼型胶基糖中。这些高熔点蜡包括蜂蜡、植物蜡、小烛树蜡、巴西棕榈蜡、大部分石 油蜡等等,及其混合物。
填充剂
在一些实施例中,使用根据本发明的教导的系统和方法所形成的咀嚼型胶基糖还可包 括有效量的增量剂,如可充当填充剂和质构改进剂(textural agent)的矿物辅助剂。有用的矿 物辅助剂包括碳酸钙、碳酸镁、氧化铝、氢氧化铝、硅酸铝、滑石、粘土、氧化钛、重质 碳酸钙、磷酸一钙、磷酸三钙、磷酸二钙、硫酸钙等等,及其混合物。这些填充剂或辅助剂可以各种量用于咀嚼型胶基糖中。填充剂的量可以占咀嚼型胶基糖的约0至约40重量%、更具体地约0至约30重量%的量存在。在一些实施例中,填充剂的量将为约0至约 15%、更具体地约3%至约11%。
抗氧化剂
抗氧化剂可包括清除自由基的材料。在一些实施例中,抗氧化剂可包括但不限于抗坏 血酸、柠檬酸(柠檬酸可以是被包封的)、迷迭香油、维生素A、维生素E、维生素E磷 酸酯、丁羟甲苯(BHT)、丁羟茴醚(BHA)、没食子酸丙酯、生育酚、二-α-生育酚磷酸酯、 生育三烯酚、α-硫辛酸、二氢硫辛酸、叶黄质、β-隐黄质、番茄红素、黄体素、玉米黄质、 虾青素、β-胡萝卜素、胡萝卜素、混合的类胡萝卜素、多酚、类黄酮,以及其组合。
后续的成分
咀嚼型胶基糖还可包括大量常规的添加剂,所述添加剂选自由增甜剂(增量甜味剂和 高强度甜味剂)、软化剂、乳化剂、填充剂、增量剂(载体、增充剂、增量甜味剂)、调 味剂(风味物、调味料)、着色剂(着色素、着色物)、功能性成分等等,以及其混合物 所组成的组。这些添加剂中有些可以起到多于一种作用。例如,在无糖咀嚼型胶基糖中, 甜味剂如麦芽糖醇或其它的糖醇还可充当增量剂特别是水溶性增量剂。
增量甜味剂
适合的增量甜味剂包括单糖、二糖和多糖,如木糖、核酮糖、葡萄糖(右旋糖)、乳糖、甘露糖、半乳糖、果糖(左旋糖)、蔗糖(食糖)、麦芽糖、转化糖、部分水解淀粉 和玉米糖浆固体、糖醇、随机键合的葡萄糖聚合物(例如以商品名LitesseTM供销的那些 聚合物,LitesseTM是聚右旋糖的品牌名,由英国RH1 6YS,Surrey,Redhill,Brighton 路41-51号的丹尼斯克甜味剂公司(Danisco Sweeteners,Ltd.)制造);异麦芽酮糖醇(isomalt) (由德国曼海姆(Mannheim,Germany)的Gotlieb-Daimler-Strause12a,68165的PalatinitSussungsmittel GmbH以商标名PALATINITTM制造的α-D-吡喃葡萄糖基-1,6-甘露糖醇和 α-D-吡喃葡萄糖基-1,6-山梨糖醇的外消旋混合物);麦芽糊精;氢化淀粉水解物;氢化己 糖;氢化二糖;矿物质,如碳酸钙、滑石、二氧化钛、磷酸二钙;纤维素;及其混合物。
适合的无糖增量甜味剂包括山梨糖醇、木糖醇、甘露糖醇、半乳糖醇、乳糖醇、麦芽糖醇、赤藓糖醇、异麦芽酮糖醇,及其混合物。适合的氢化淀粉水解物包括那些在美国专 利第4,279,931号中公开的氢化淀粉水解物以及包含山梨糖醇、麦芽糖醇、氢化二糖、氢 化高级多糖或其混合物的各种氢化葡萄糖浆和/或粉末。氢化淀粉水解物主要经由对玉米 糖浆的受控催化氢化来制备。所得的氢化淀粉水解物是单糖、二糖和多糖的混合物。这些 不同的糖化物的比例赋予不同的氢化淀粉水解物不同的性质。氢化淀粉水解物的混合物也 是有用的,所述氢化淀粉水解物的混合物例如由法国Roquette Freres制造的市售产品和由美国特拉华州纽卡斯尔市(New Castle)的SPI Polyols公司制造的市售产品
咀嚼型胶基糖的一些实施例可包括特定的多元醇组合物,所述多元醇组合物包括至少 一种多元醇,所述多元醇组合物占所述咀嚼型胶基糖的约30重量%至约80重量%,更具 体地约50重量%至约60重量%。在一些实施例中,这样的咀嚼型胶基糖可具有低的吸湿性。所述多元醇组合物可包括任何本领域已知的多元醇,包括但不限于麦芽糖醇、山梨糖醇、赤藓糖醇、木糖醇、甘露糖醇、异麦芽酮糖醇、乳糖醇,及其组合。还可以使用来卡 生(Lycasin)TM,其是一种包括山梨糖醇和麦芽糖醇的氢化淀粉水解物。
在咀嚼型胶基糖中使用的所述多元醇组合物或多元醇组合的量将取决于许多因素,所 述因素包括在所述咀嚼型胶基糖中使用的弹性体和多元醇的类型。例如,其中,所述多元 醇组合物的总量基于所述咀嚼型胶基糖的重量在约40%至约65%的范围内,异麦芽酮糖醇 的量基于所述咀嚼型胶基糖的重量可为约40%至约60%,加上山梨糖醇的量约0%至最高 约10%,更具体地,异麦芽酮糖醇的量可为约45%至约55%,与约5%至约10%的山梨糖 醇组合。
所述多元醇组合物可包括一种或多种不同的可源自转基因生物(“GMO”)或源自非转 基因生物(GMO-free)的多元醇。例如,麦芽糖醇可以是非转基因生物的麦芽糖醇或经由氢化淀粉水解物提供。出于本发明的目的,术语“非转基因生物的”指已经源自其中未利用转基因生物的工艺的成分。
可包括在使用根据本发明的教导的系统和方法所形成的一些咀嚼型胶基糖中的甜味 剂可以是本领域已知的多种甜味剂中的任何一种,并且可以本领域公知的许多不同物理形 式使用以提供初始的甜味突释和/或延长的甜味感觉。这样的物理形式包括但不限于多种 游离形式,如喷雾干燥的、粉末状的、珠状的形式,包封的形式,及其混合物。
高强度甜味剂
有利地,甜味剂是诸如阿斯巴甜、纽甜、三氯蔗糖、莫那亭和乙酰磺胺酸钾(Ace-K)的高强度甜味剂。所述高强度甜味剂可以是被包封的形式、游离形式或二者。
一般来说,可利用有效量的甜味剂来提供期望的甜度水平,并且这个量可随所选的甜 味剂而变化。在一些实施例中,取决于所使用的甜味剂或甜味剂组合,甜味剂的量可以占 胶基糖的约0.001重量%至约3重量%的量存在。每种类型的甜味剂的量的确切范围可由 本领域的技术人员选择。
所涉及的甜味剂可选自广泛范围的材料,包括水溶性甜味剂、水溶性人工甜味剂、源 自天然存在的水溶性甜味剂的水溶性甜味剂、基于二肽的甜味剂、以及基于蛋白质的甜味 剂,包括其混合物在内。不局限于特定的甜味剂,不过代表性的类别和例子包括:
(a)水溶性甜味剂,如二氢查尔酮、莫尼林(monellin)、甜菊苷、罗汉果、罗汉果衍生 物、甘草甜素、黄烷酮醇(dihydroflavenol)及糖醇(如山梨糖醇、甘露糖醇、麦芽糖醇、木 糖醇、赤藓糖醇)、及如美国专利第4,619,834号(该专利的公开内容以引用方式并入本文)中公开的L-氨基二羧酸氨基链烯酸酯酰胺,及其混合物;
(b)水溶性人工甜味剂,如可溶性糖精盐(即糖精钠或糖精钙盐)、环己基氨基磺酸盐、3,4-二氢-6-甲基-1,2,3-恶噻嗪-4-酮-2,2-二氧化物的钠盐、铵盐或钙盐、3,4-二氢-6-甲 基-1,2,3-恶噻嗪-4-酮-2,2-二氧化物的钾盐(乙酰磺胺酸钾,Acesulfame-K)、糖精的游离 酸形式,及其混合物;
(c)基于二肽的甜味剂,如源自L-天冬氨酸的甜味剂,如L-天冬氨酰-L-苯丙氨酸甲酯 (阿斯巴甜)、N-[N-(3,3-二甲基丁基)-L-α-天冬氨酰]-L-苯丙氨酸1-甲酯(纽甜),以及 美国专利第3,492,131号中描述的材料、L-α-天冬氨酰-N-(2,2,4,4-四甲基-3-硫化三亚甲 基)-D-丙氨酰胺水合物(阿力甜)、L-天冬氨酰-L-苯基甘油以及L-天冬氨酰-L-2,5-二氢苯 基-甘氨酸的甲酯、L-天冬氨酰-2,5-二氢-L-苯丙氨酸;L-天冬氨酰-L-(1-环已烯)-丙氨酸, 及其混合物;
(d)源自天然存在的水溶性甜味剂的水溶性甜味剂,如普通食糖(蔗糖)的氯化衍生 物,例如氯化脱氧糖衍生物(如氯化脱氧蔗糖或氯化脱氧半乳蔗糖的衍生物,例如以三氯 蔗糖(Sucralose)的产品名称为人所知);氯化脱氧蔗糖和氯化脱氧半乳蔗糖衍生物的例子 包括但不限于:1-氯-1'-脱氧蔗糖;4-氯-4-脱氧-α-D-半乳吡喃糖基-α-D-呋喃果糖苷,或4- 氯-4-脱氧半乳蔗糖;4-氯-4-脱氧-α-D-半乳吡喃糖基-1-氯-1-脱氧-β-D-果糖-呋喃糖苷,或 4,1'-二氯-4,1'-二脱氧半乳蔗糖;1',6'-二氯1',6'-二脱氧蔗糖;4-氯-4-脱氧-α-D-半乳吡喃糖基 -1,6-二氯-1,6-二脱氧-β-D-呋喃果糖苷,或4,1',6'-三氯-4,1',6'-三脱氧半乳蔗糖;4,6-二氯-4,6- 二脱氧-α-D-半乳吡喃糖基-6-氯-6-脱氧-β-D-呋喃果糖苷,或4,6,6'-三氯-4,6,6'-三脱氧半乳 蔗糖;6,1',6'-三氯-6,1',6'-三脱氧蔗糖;4,6-二氯-4,6-二脱氧-α-D-半乳-吡喃糖基-1,6-二氯-1,6- 二脱氧-β-D-呋喃果糖苷,或4,6,1',6'-四氯4,6,1',6'-四脱氧半乳糖-蔗糖;以及4,6,1',6'-四脱 氧蔗糖,及其混合物;
(e)基于蛋白质的甜味剂,如非洲竹芋甜素(thaumaoccous denielli)(索马甜I和II)和 塔林(talin);以及
(f)甜味剂莫那亭(monatin)(2-羟基-2-(吲哚-3-基甲基)-4-氨基戊二酸)及其衍生物。
高强度甜味剂可以本领域公知的许多不同的物理形式使用,以提供初始的甜味突释和 /或延长的甜味感觉。这样的物理形式包括但不限于游离形式、喷雾干燥形式、粉末状形 式、珠状形式、包封的形式,及其混合物。在一个实施例中,甜味剂是诸如阿斯巴甜、三氯蔗糖和乙酰磺胺酸钾(例如,Ace-K或乙酰磺胺酸-K)的高强度甜味剂。包封的甜味剂 的几种代表性形式和包封甜味剂的方法在美国专利第7,244,454号、第7,022,352号、第 6,759,066号、第5,217,735号、第5,192,561号、第5,164,210号、第4,997,659号和第4,981,698 号以及美国专利申请公开第2007/0231424号、第2004/0096544号、第2005/0112236号和 第2005/0220867号中有说明,所述专利和专利申请的教导和公开内容以引用方式整体并 入本文。
作为递送系统的一部分的活性组分(例如甜味剂),可以赋予与所述活性组分(例如 甜味剂)的使用相关的期望效果所需要的量来使用。一般来说,可利用有效量的强力甜味 剂来提供期望的甜度水平,并且这个量可随所选的甜味剂而变化。取决于所使用的甜味剂 或甜味剂组合,强力甜味剂可以占组合物的约0.001重量%至约3重量%的量存在。每种类型的甜味剂的量的确切范围可由本领域的技术人员选择。
糖浆
无水甘油也可作为软化剂采用,例如市售的美国药典(USP)级无水甘油。甘油是具有 甘甜温热味道的糖浆状液体,其甜度是蔗糖甜度的约60%。由于甘油是吸湿的,在咀嚼型 胶基糖的整个制备过程中,可将无水甘油维持在无水条件下。其它糖浆可包括玉米糖浆和 麦芽糖醇糖浆。
风味料
在一些实施例中,风味料可包括技术人员已知的那些风味物,如天然和人造风味物。 这些调味料可选自合成风味油和调味芳香品和/或油,油树脂和源自植物、叶、花、果实等等的提取物,以及其组合。非限制性的代表性风味油包括留兰香油(spearmint oil)、 肉桂油、冬青油(水杨酸甲酯)、胡椒薄荷油、日本薄荷油、丁香油、月桂油、大茴香油、 桉树油、百里香油、雪松叶油、肉豆蔻油、多香果、鼠尾草油、肉豆蔻衣、苦杏仁油和桂 皮油。同样可用的调味料是人工的、天然的和合成的水果风味物,如香草和柑橘油(包括 柠檬、橙、莱母酸橙、葡萄柚、yazu、酸橘),以及水果香精(包括苹果、梨、桃、葡萄、 蓝莓、草莓、树莓、樱桃、李子、菠萝、杏、香蕉、甜瓜、杏、梅子(ume)、樱桃、树莓、 黑莓、热带果、芒果、山竹果、石榴、番木瓜果等等)。释放情况可被操控的其它潜在的 风味物包括乳风味物、黄油风味物、干酪风味物、奶油风味物和酸奶风味物;香草风味物; 茶或咖啡风味物,如绿茶风味物、乌龙茶风味物、茶风味物、可可风味物、巧克力风味物 和咖啡风味物;薄荷风味物,如胡椒薄荷风味物、留兰香风味物和日本薄荷风味物;辛辣 风味物,如阿魏风味物、印度藏茴香(ajowan)风味物、大茴香风味物、当归风味物、茴香 风味物、多香果风味物、肉桂风味物、甘菊风味物、芥末风味物、小豆蔻风味物、香菜风 味物、孜然风味物、丁香风味物、胡椒风味物、芫荽风味物、黄樟风味物、香薄荷风味物、 花椒风味物、紫苏风味物、杜松子风味物、生姜风味物、八角风味物、辣根风味物、百里 香风味物、龙蒿风味物、莳萝风味物、菜椒风味物、肉豆蔻风味物、罗勒风味物、马郁兰 风味物、迷迭香风味物、月桂叶风味物和青芥辣(wasabi)(日本辣根)风味物;酒类风味 物,如葡萄酒风味物、威士忌风味物、白兰地风味物、朗姆酒风味物、杜松子酒风味物和 利口酒风味物;花卉风味物;以及蔬菜风味物,如洋葱风味物、大蒜风味物、卷心菜风味 物、胡萝卜风味物、芹菜风味物、蘑菇风味物和番茄风味物。这些调味剂可以液体或固体 形式使用,并且可单独使用或以混合物的形式使用。常用的风味物包括薄荷类(如胡椒薄 荷、薄荷醇、留兰香)、人工香草、肉桂衍生物和各种水果风味物,不论是单独采用或是 以混合物的形式采用。风味物还可提供口气清新性质,尤其是薄荷风味物在与下文所述的 清凉剂组合使用时。在一些实施例中,风味料可选自香叶醇、芳樟醇、橙花醇、橙花叔醇、 香茅醇、洋茉莉醛、甲基环戊烯酮、乙基香兰素、麦芽酚、乙基麦芽酚、呋喃酮、葱味化 合物、玫瑰型化合物如苯乙醇、苯乙酸、橙花醇、芳樟酯、茉莉、檀木、广藿香和/或雪 松。
在一些实施例中,可使用其它调味料,包括醛类和酯类,如乙酸肉桂酯、肉桂醛、柠檬醛二乙缩醛、乙酸二氢香芹酯、甲酸丁香酚酯、对甲基茴香醚等等。通常,可使用任何 调味料或食品添加剂,如在美国国家科学院的“Chemicals Used in Food Processing”(《食品加工中使用的化学品》)(出版物1274,第63-258页)中所描述的那些调味料或食品 添加剂。该出版物以引用方式并入本文。这些可包括天然的以及合成的风味物。
醛类调味料的更多例子包括但不限于:乙醛(苹果)、苯甲醛(樱桃、杏仁)、大茴 香醛(甘草、大茴香)、肉桂醛(肉桂)、柠檬醛即α-柠檬醛(柠檬、酸橙)、橙花醛即 β-柠檬醛(柠檬、莱母酸橙)、癸醛(橙、柠檬)、乙基香草醛(香草、乳脂)、天芥菜 精即胡椒醛(香草、乳脂)、香草醛(香草、乳脂)、α-戊基肉桂醛(有香辛味的果味风 味物)、丁醛(黄油、干酪)、戊醛(黄油、干酪)、香茅醛(改性产物、多种类型)、 癸醛(柑橘类水果)、醛C-8(柑橘类水果)、醛C-9(柑橘类水果)、醛C-12(柑橘类 水果)、2-乙基丁醛(浆果类水果)、己烯醛即反-2(浆果类水果)、甲苯醛(樱桃、杏 仁)、藜芦醛(香草)、2,6-二甲基-5-庚烯醛即甜瓜醛(甜瓜)、2,6-二甲基辛醛(未熟 水果)、以及2-十二烯醛(柑橘类、中国柑桔)、樱桃、葡萄、蓝莓、黑莓、草莓酥饼(shortcake), 及其混合物。
在一些实施例中,调味剂以提供可感知的感觉体验的水平使用,即以其阈值水平或高 于其阈值水平来使用。在其它的实施例中,调味剂以低于其阈值水平的水平来使用,从而 它们不提供独立的可感知的感觉体验。在阈下水平,调味剂可提供辅助性益处,如风味提 升或增强。
在一些实施例中,调味剂可以液体的形式和/或干燥的形式采用。当以后一种形式采 用时,可使用适合的干燥方式,例如喷雾干燥所述液体。作为另一种选择,调味剂可被吸收到水溶性材料(例如纤维素、淀粉、食糖、麦芽糊精、阿拉伯树胶等等)上,或可被包 封。在另外其它的实施例中,调味剂可以吸附到二氧化硅、沸石等等上。
在一些实施例中,调味剂可以许多不同的物理形式来使用。这样的物理形式包括但不 限于游离形式,如喷雾干燥的、粉末状的、珠状的形式,被包封的形式,及其混合物。
对风味物以及其它附加组分的包封的说明可在本文提供的实例中找到。典型地,组分 的包封将导致在包括所述被包封组分的咀嚼型胶基糖(所述被包封组分例如作为递送系统 的一部分,所述递送系统作为成分被添加至所述咀嚼型胶基糖)的消费期间,所述组分的 大部分的量的释放延迟。在一些实施例中,所述成分(例如,风味物、甜味剂等)的释放 情况可以经由操控所述成分、含有所述成分的递送系统、和/或含有所述递送系统的咀嚼 型胶基糖的各种特性和/或操控所述递送系统如何制造来进行操控。例如,特性可包括下 面的一项或多项:所述递送系统的拉伸强度、所述成分的水溶解度、所述包封材料的水溶 解度、所述递送系统的水溶解度、所述递送系统中成分与包封材料的比例、成分的平均粒 度或最大粒度、研磨的递送系统的平均粒度或最大粒度、所述咀嚼型胶基糖中所述成分或 所述递送系统的量、用于包封一种或更多种成分的不同聚合物的比例、用于包封一种或多 种成分的一种或多种聚合物的疏水性、所述递送系统的疏水性、所述递送系统上的包衣的 类型或量、成分被包封前在所述成分上的包衣的类型或量,等等。
感知物成分
感知物化合物可包括清凉剂、温热剂、麻刺剂、泡腾剂及其组合。可采用多种公知的 清凉剂。例如,有用的清凉剂中包括木糖醇、赤藓糖醇、右旋糖、山梨糖醇、薄荷烷、薄 荷酮、缩酮、薄荷酮缩酮、薄荷酮甘油缩酮、取代的对薄荷烷、无环羧酰胺、戊二酸单薄 荷醇酯、取代的环己酰胺、取代的环己甲酰胺、取代的脲和磺胺、取代的薄荷醇、羟甲基 对薄荷烷和对薄荷烷的羟甲基衍生物、2-巯基-环-癸酮、具有2-6个碳原子的羟基羧酸、 环己酰胺、乙酸薄荷酯、水杨酸薄荷酯、N,2,3-三甲基-2-异丙基丁酰胺(WS 23)、N-乙基- 对薄荷烷-3-羧酰胺(WS 3)、异蒲勒醇、3-(1-薄荷氧基)丙-1,2-二醇、3-(1-薄荷氧基)-2-甲基丙-1,2-二醇、对薄荷烷-2,3-二醇、对薄荷烷-3,8-二醇、6-异丙基-9-甲基-l,4-二氧杂螺[4,5] 癸烷-2-薄荷醇、琥珀酸薄荷酯及其碱土金属盐、三甲基环己醇、N-乙基-2-异丙基-5-甲基 环己甲酰胺、日本薄荷油、胡椒薄荷油、3-(l-薄荷氧基)乙-l-醇、3-(l-薄荷氧基)丙-l-醇、3-(l- 薄荷氧基)丁-l-醇、1-薄荷基乙酸N-乙酰胺、l-薄荷基-4-羟基戊酸酯、1-薄荷基-3-羟基丁酸 酯、N,2,3-三甲基-2-(l-甲基乙基)-丁酰胺、正乙基-t-2-c-6壬二烯酰胺、N,N-二甲基薄荷基 琥珀酰胺、取代的对薄荷烷、取代的对薄荷烷甲酰胺、2-异丙基-5-甲基环己醇(得自日本 久光制药株式会社(Hisamitsu Pharmaceuticals),下文称“isopregol”);薄荷酮甘油缩酮 (FEMA 3807,商品名MGA类型);3-l-甲氧基丙-l,2-二醇(得自日本高 砂香料工业株式会社(Takasago),FEMA 3784);及乳酸薄荷酯(得自Haarman&Reimer 公司,FEMA 3748,商品名ML类型)、WS-30、WS-14、桉树提取物(对 薄荷基-3,8-二醇)、薄荷醇(其天然或合成衍生物)、薄荷醇PG碳酸酯、薄荷醇EG碳 酸酯、薄荷醇甘油醚、N-叔丁基-对薄荷烷-3-甲酰胺、对薄荷烷-3-羧酸甘油酯、甲基-2-异 丙基(isopryl)-二环(2.2.1)、庚烷-2-甲酰胺;以及薄荷醇甲基醚,以及薄荷基吡咯烷酮羧酸 酯,等等。这些和其它适合的清凉剂在以下美国专利(所有这些专利以引用方式整体并入 本文)中有进一步的描述:美国专利第4,230,688号;第4,032,661号;第4,459,425号; 第4,136,163号;第5,266,592号;第6,627,233号。
在一些实施例中,温热剂组分可选自广泛种类的已知能给使用者提供温热感觉信号的 化合物。这些化合物给予温热的感知感觉,特别是在口腔中,并且常常增强风味物、甜味 剂和其它感官组分的感知。在一些实施例中,有用的温热剂包括香草醇正丁基醚(TK-1000) (日本东京的日本高砂香料工业株式会社(Takasago Perfumary Company Limited)供应)、 香草醇正丙基醚、香草醇异丙基醚、香草醇异丁基醚、香草醇正氨基醚、香草醇异戊基醚、 香草醇正己基醚、香草醇甲基醚、香草醇乙基醚、姜醇、生姜酚、非洲豆蔻醇(paradol)、 姜油酮、辣椒素、二氢辣椒素、降二氢辣椒素、高辣椒素、高二氢辣椒素、乙醇、异丙醇、 异戊醇、苯甲醇、甘油或其组合。
在一些实施例中,可提供麻刺感觉。一种这样的麻刺感觉是经由向一些实例加入金纽 扣(jambu)、油树脂或千日菊素(spilanthol)而提供的。在一个实施例中,可包括从诸如金钮 扣或山椒的材料提取的烷基酰胺。此外,在一些实施例中,感觉因泡腾而创建。这样的泡 腾是经由将碱性材料与酸性材料进行组合而创建的。在一些实施例中,碱性材料可包括碱 金属碳酸盐、碱金属碳酸氢盐、碱土金属碳酸盐、碱土金属碳酸氢盐及其组合。在一些实 施例中,酸性材料可包括乙酸、己二酸、抗坏血酸、丁酸、柠檬酸、甲酸、富马酸、葡糖 酸(glyconic acid)、乳酸、磷酸、苹果酸、草酸、琥珀酸、酒石酸及其组合。“麻刺”类型的 感知物的例子可在美国专利第6,780,443号中找到,为了所有目的,将该专利的整体内容 以引用方式并入本文。
感知物组分还可被称为“三叉神经刺激物”,如在美国专利申请第205/0202118号中所 公开的那些,该美国专利申请以引用方式并入本文。三叉神经刺激物被定义为一种刺激三 叉神经的口服产品或口服剂。属于三叉神经刺激物的清凉剂的例子包括薄荷醇、WS-3、 N-取代的对薄荷烷羧酰胺、包括WS-23的无环羧酰胺、琥珀酸甲酯、薄荷酮甘油缩酮、 增量甜味剂如木糖醇、赤藓糖醇、右旋糖和山梨糖醇,及其组合。三叉神经刺激物还可包 括风味物、麻刺剂、金纽扣提取物、香草基烷基醚如香草基正丁醚、千日菊酰胺、紫锥菊 提取物、美洲花椒提取物、辣椒碱、辣椒碱油树脂、红椒油树脂、黑胡椒油树脂、胡椒碱、 生姜油树脂、姜醇、姜烯酚、肉桂油树脂、桂皮油树脂、肉桂醛、丁子香酚、香兰素的环 缩醛和薄荷醇甘油醚、不饱和酰胺,及其组合。
在一些实施例中,感知物组分以提供可感知的感觉体验的水平即以其阈值水平或高于 其阈值水平来使用。在其它的实施例中,感知物组分以低于其阈值水平的水平来使用,从 而它们不提供独立的可感知的感觉体验。在阈下水平,感知物可提供辅助性益处,如风味 或甜味提升或增强。
增强剂成分
增强剂包括这样的材料,所述材料能强化、补充、修饰或提升原始材料的味道和/或 芳香感知,而又不引入其自身的特征性味道和/或芳香感知。在一些实施例中,可包括被设计用于强化、补充、修饰或提升风味、甜味、酸味、鲜味(umami)、淳厚味(kokumi)、咸 味及其组合的感知的增强剂。
在一些实施例中,合适的增强剂(也称为味道增强剂)的例子包括但不限于新橙皮苷 二氢查耳酮、绿原酸、阿拉哒嗪(alapyridaine)、洋蓟酸、奇异果素(miraculin)、谷哒嗪(glupyridaine)、吡啶-甜菜碱化合物、谷氨酸盐如谷氨酸单钠盐和谷氨酸单钾盐、纽甜、索马甜、塔格糖、海藻糖、盐类如氯化钠、甘草酸单铵盐、香草提取物(在乙醇中)、糖酸 类、氯化钾、酸式硫酸钠、水解植物蛋白、水解动物蛋白、酵母提取物、腺苷一磷酸(AMP)、 谷胱甘肽、核苷酸如肌苷单磷酸、肌苷酸二钠盐、黄苷单磷酸、鸟苷单磷酸、阿拉哒嗪(N-(1- 羧乙基)-6-(羟甲基)吡啶鎓-3-醇内盐)、甜菜提取物(醇提取物)、甘蔗叶香精(醇提取 物)、仙茅蛋白(curcurin)、斯特罗青(strogin)、马槟榔甜蛋白(mabinlin)、匙羹藤酸(gymnemicacid)、对羟基苯甲酸、3-氢苯甲酸、2,4-二氢苯甲酸、苦橙(citrus aurantium)、香草油树脂、 甘蔗叶香精、麦芽酚、乙基麦芽酚、香草醛、甘草的甘草酸盐、响应G蛋白偶联受体(T2R和T1R)的化合物以及赋予淳厚味的味道增强剂组合物,如在Kuroda等人的美国专利第 5,679,397号中所公开的,所述专利以引用方式整体并入本文。“淳厚味”指赋予“满口感(mouthfulness)”和“浓稠感(good body)”的材料。
甜味增强剂作为一种味道增强剂,能提升甜味。在一些实施例中,示例性的甜味增强 剂包括但不限于甘草酸单铵盐、甘草的甘草酸盐、苦橙、阿拉哒嗪、阿拉哒嗪(N-(1-羧乙基)-6-(羟甲基)吡啶鎓-3-醇)内盐)、奇异果素、仙茅蛋白、斯特罗青、马槟榔甜蛋白、匙羹藤酸、洋蓟酸、谷哒嗪、吡啶-甜菜碱化合物、甜菜提取物、纽甜、索马甜、新橘皮苷二 氢查耳酮、对羟基苯甲酸、塔格糖、海藻糖、麦芽酚、乙基麦芽酚、香草提取物、香草油 树脂、香草醛、甜菜提取物(醇提取物)、甘蔗叶香精(醇提取物)、响应G蛋白偶联受 体(T2R和T1R)的化合物及其组合。
其它的用于提升咸味的增强剂的例子包括酸性肽,如那些在美国专利第6,974,597号 中公开的酸性肽,该专利以引用方式并入本文。酸性肽包括具有的酸性氨基酸(如天冬氨 酸和谷氨酸)的数目比碱性氨基酸(如赖氨酸、精氨酸和组氨酸)的数目更多的肽。酸性 肽是经由肽合成或经由将蛋白质用肽链内切酶水解,且如果需要的话,经由脱酰胺作用而 获得的。适用于生产酸性肽或经由将蛋白水解和脱酰胺作用而获得的肽的蛋白质包括植物 蛋白(例如面筋、玉米蛋白(例如玉米醇溶蛋白和面筋粉)、大豆分离蛋白)、动物蛋白(例如乳蛋白,如乳酪蛋白和乳清蛋白、肌蛋白如肉类蛋白和鱼肉蛋白、卵白蛋白和胶原 蛋白)以及微生物蛋白(例如微生物细胞蛋白和由微生物产生的多肽)。
温热或清凉效果的感觉也可使用如美国专利申请公开第2003/0072842A1中描述的疏 水甜味剂来延长,该专利申请以引用方式整体并入本文。
食品酸度剂成分
酸可包括但不限于乙酸、己二酸、抗坏血酸、丁酸、柠檬酸、甲酸、富马酸、葡糖酸、乳酸、磷酸、苹果酸、草酸、琥珀酸、酒石酸、天冬氨酸、苯甲酸、咖啡鞣酸、异柠檬酸、 柠苹酸、半乳糖醛酸、葡糖醛酸、甘油酸、乙醇酸、酮戊二酸、α-酮戊二酸、乳异柠檬酸、 草酰乙酸、丙酮酸、奎尼酸、莽草酸、琥珀酸、鞣酸、羟乙酸、辛二酸、癸二酸、壬二酸、 庚二酸、癸酸及其组合。
乳化剂
咀嚼型胶基糖还可包括乳化剂,所述乳化剂有助于将不互溶的组分散到单一的稳定体 系中。本发明中可用的乳化剂包括单独使用的单硬脂酸甘油酯、卵磷脂、脂肪酸单甘油酯、 二甘油酯、单硬脂酸丙二醇酯、甲基纤维素、海藻酸盐、角叉菜胶、黄原胶、明胶、角豆树胶、黄芪胶、刺槐豆胶、果胶、海藻酸盐、半乳甘露聚糖如瓜尔胶、角豆树豆胶、葡甘 露聚糖、明胶、淀粉、淀粉衍生物、糊精和纤维素衍生物如羧甲基纤维素、酸化剂如苹果 酸、己二酸、柠檬酸、酒石酸、富马酸等等,及其混合物。乳化剂可以占咀嚼型胶基糖的 约2重量%至约15重量%、更具体地约7重量%至约11重量%的量来使用。
色素
着色剂可以能有效产生期望的颜色的量来使用。着色剂可包括色素,所述色素可以最 高占胶基糖的约6重量%的量掺入。例如,二氧化钛可以最高占咀嚼型胶基糖的约2重量 %、优选小于约1重量%的量掺入。着色素还可包括天然食用色素和适合于食品、药品和化妆品应用的染料。这些着色素被称为F.D.&C.染料和色淀。对于前述用途而言可接受的材料优选为水溶性的。示例性的非限制性例子包括被称为F.D.&C.蓝2号的靛类染料,它 是5,5-靛蓝二磺酸的二钠盐。类似地,被称为F.D.&C.绿1号的染料包括三苯甲烷染料, 并且是4-[4-(N-乙基-对锍苄基氨基)二苯基亚甲基]-[1-(N-乙基-N-对锍苄基)-δ-2,5-环已二烯亚胺]的一钠盐。关于所有F.D.&C.着色素的完整叙述及它们相应的化学结构可以从Kirk-Othmer Encyclopedia of Chemical Technology(《Kirk-Othmer化学工艺百科全书》), 第3版,第5卷,第857-884页中找到,此文本以引用方式并入本文。
根据美国食品、药品和化妆品法案(21C.F.R.73)的分类,色素可包括免除认证的色素 (有时称为天然的,尽管其可经由合成法制造)以及认证色素(有时称为人造的)或其组 合。在一些实施例中,免除认证的或天然的色素可包括但不限于胭脂树提取物(E160b)、胭脂树橙、降胭脂树橙、虾青素、脱水甜菜(甜菜粉)、甜菜根红/甜菜苷(E162)、群青蓝、 角黄素(E161g)、隐黄质(E161c)、玉红黄质(E161d)、淡红黄质(E161e)、玫红黄质(E161f)、 焦糖(E150(a-d))、β-阿朴-8'-胡萝卜素醛(E160e)、β-胡萝卜素(E160a)、α-胡萝卜素、γ-胡萝 卜素、β-阿朴-8'-胡萝卜素醛乙酯(E160f)、毛莨黄素(E161a)、黄体素(E161b)、胭脂虫提取 物(E120)、胭脂红(E132)、酸性红/偶氮玉红(E122)、铜叶绿酸钠(E141)、叶绿素(E140)、部 分烤制脱脂熟棉籽粉、葡萄糖酸亚铁、乳酸亚铁、葡萄色提取物(grape color extract)、葡萄皮提取物(葡萄花青素)、花青素(E163)、雨生红球藻粉、合成氧化铁、铁氧化类和氢氧 化物类(E172)、果汁、蔬菜汁、干藻粉、万寿菊(阿兹特克(Aztec)万寿菊)粉和提取物、 胡萝卜油、玉米胚乳油、红辣椒、红辣椒油树脂、法夫红酵母、核黄素(E101)、藏红花、 二氧化钛、姜黄(E100)、姜黄油树脂、苋菜红(E123)、辣椒红/辣椒玉红素(E160c)、番茄红 素(E160d),及其组合。
在一些实施例中,认证色素可包括但不限于FD&C蓝1号、FD&C蓝2号、FD&C绿 3号、FD&C红3号、FD&C红40号、FD&C黄5号和FD&C黄6号、酒石黄(E102)、喹 啉黄(E104)、日落黄(E110)、丽春花红(E124)、赤藓红(E127)、专利蓝V(E131)、二氧化钛 (E171)、铝(E173)、银(E174)、金(E175)、颜料玉红/立索玉红BK(E180)、碳酸钙(E170)、 炭黑(E153)、黑PN/亮黑BN(E151)、绿S/酸亮绿BS(E142),及其组合。在一些实施例中, 认证色素可包括FD&C铝色淀。这些包括在水合氧化铝的不溶性基材上延展的FD&C染 料的铝盐。另外,在一些实施例中,认证色素可作为钙盐被包括。
功能性成分
包括功能性成分的额外的添加剂包括生理清凉剂、咽喉舒缓剂、香辛料、温热剂、牙 齿增白剂或其它牙科护理成分、口气清新剂、维生素、营养剂、植物化学品、多酚、抗氧化剂、活性成分、矿物质、咖啡因、药物,并且其它活性物也可包括在胶基糖组合物中。 这样的组分可以足够达到其预定效果的量来使用,并且将在下文进行更充分地讨论。
口气清新成分
口气清新剂可包括精油以及各种醛、醇以及类似的材料。在一些实施例中,精油可包 括留兰香、胡椒薄荷、冬青、黄樟、叶绿素、柠檬醛、香叶醇、小豆蔻、丁香、鼠尾草、 香芹酚、桉树、小豆蔻、厚朴提取物、马郁兰、肉桂、柠檬、莱母酸橙、葡萄柚和橙的油。 在一些实施例中,可使用诸如肉桂醛和水杨醛的醛类。另外,诸如薄荷醇、香芹酮、 iso-garrigol以及茴香脑的化学品可以起口气清新剂的作用。在这些物质中,最常用的是胡 椒薄荷、留兰香和叶绿素的油。
除了精油和从其衍生的化学品之外,在一些实施例中,口气清新剂还可包括但不限于: 柠檬酸锌、乙酸锌、氟化锌、硫酸锌铵、溴化锌、碘化锌、氯化锌、硝酸锌、氟硅酸锌、葡萄糖酸锌、酒石酸锌、琥珀酸锌、甲酸锌、铬酸锌、苯酚磺酸锌、连二硫酸锌、硫酸锌、 硝酸银、水杨酸锌、甘油磷酸锌、硝酸铜、叶绿素、叶绿素铜、叶绿酸、氢化棉籽油、二 氧化氯、β-环糊精、沸石、硅石基材料、碳基材料、酶类如漆酶,及其组合。
在一些实施例中,咀嚼型胶基糖的益生菌的释放情况可被操控,所述益生菌包括但不 限于:产乳酸微生物如凝结芽孢杆菌(Bacillus coagulans)、枯草芽孢杆菌(Bacillus subtilis)、 侧芽孢杆菌(Bacillus laterosporus)、左旋乳酸芽孢杆菌(Bacillus laevolacticus)、菊糖芽孢乳 杆菌(Sporolactobacillus inulinus)、嗜酸乳杆菌(Lactobacillus acidophilus)、弯曲乳杆菌 (Lactobacillus curvatus)、植物乳杆菌(Lactobacillus plantarum)、詹氏乳杆菌(Lactobacillus jenseni)、干酪乳杆菌(Lactobacillus casei)、发酵乳酸杆菌(Lactobacillus fermentum)、乳酸乳 球菌(Lactobacillus lactis)、乳酸片球菌(Pedioccocus acidilacti)、戊糖片球菌(Pedioccocus pentosaceu)、尿道片球菌(Pedioccocus urinae)、肠膜明串珠菌(Leuconostoc mesenteroides)、 凝结芽孢杆菌(Bacillus coagulans)、枯草芽孢杆菌(Bacillus subtilis)、侧芽孢杆菌(Bacillus laterosporus)、左旋乳酸芽孢杆菌(Bacillus laevolacticus)、菊糖芽孢乳杆菌(Sporolactobacillus inulinus)及其混合物。口气清新剂还以下列商品名为人所知:RetsynTM、ActizolTM和 NutrazinTM。口臭控制组合物的例子也被包括在Stapler等人的美国专利第5,300,305号中以 及在美国专利申请公开第2003/0215417号和第2004/0081713号中,为了所有目的,将所 述的专利和专利申请以引用方式整体并入本文。
牙科护理成分
牙科护理成分(也称为口腔护理成分)可包括但不限于牙齿增白剂、渍斑脱除剂、口 腔清洁剂、漂白剂、脱敏剂、牙齿再矿化剂、抗菌剂、抗龋剂、牙斑酸缓冲剂、表面活性 剂和抗牙石剂。这样的成分的非限制性例子可包括水解剂(包括蛋白水解酶)、摩擦剂(如 水合二氧化硅、碳酸钙、碳酸氢钠和氧化铝),其它活性的除渍组分如表面活性物剂,包 括但不限于阴离子表面活性剂如硬脂酸钠、棕榈酸钠、硫酸化油酸丁酯、油酸钠、富马酸 的盐、甘油、羟基化卵磷脂、月桂基硫酸钠,以及螯合剂如聚磷酸盐(其典型地作为牙垢 控制成分采用)。在一些实施例中,牙科护理成分还可包括焦磷酸四钠和三聚磷酸钠、碳 酸氢钠、酸式焦磷酸钠、三聚磷酸钠、木糖醇、六偏磷酸钠。
在一些实施例中,包括过氧化物如过氧化脲、过氧化钙、过氧化镁、过氧化钠、过氧化氢和过氧二磷酸。在一些实施例中,包括硝酸钾和柠檬酸钾。其它的例子可包括酪蛋白糖巨肽、钙酪蛋白胨-磷酸钙、酪蛋白磷酸肽、酪蛋白磷酸肽-无定型磷酸钙(CPP-ACP)和 无定型磷酸钙。另外其它的例子可包括木瓜蛋白酶、磷虾酶、胃蛋白酶、胰蛋白酶、溶菌 酶、葡聚糖酶、齿斑葡聚糖酶(mutanase)、糖化酶、淀粉酶、葡萄糖氧化酶,及其组合。
更多的例子可包括用于一些实施例中以提高预防作用并使牙科护理成分在美容上更 可接受的表面活性剂,如硬脂酸钠、蓖麻油酸钠和月桂基硫酸钠表面活性剂。表面活性剂 可优选为赋予组合物清洁及起泡性能的清洁材料。表面活性剂的合适例子有水溶性的高级 脂肪酸单甘油酯单硫酸盐如氢化椰子油脂肪酸的单硫酸化单甘油酯的钠盐、高级烷基硫酸 盐如月桂基硫酸钠、烷基芳基磺酸盐如十二烷基苯磺酸钠、磺基乙酸高级烷基酯、月桂基 磺基乙酸钠、1,2-二羟基丙烷磺酸盐的高级脂肪酸酯以及低级脂族氨基羧酸化合物的基本 上饱和的高级脂族酰胺,如那些在脂肪酸、烷基或酰基等中具有12到16个碳原子的化合 物。最后提到的酰胺的例子有N-月桂酰肌氨酸,以及N-月桂酰、N-肉豆蔻酰或N-棕榈酰 肌氨酸的钠、钾和乙醇胺盐。
除了表面活性剂以外,牙科护理成分可包括抗菌剂如但不限于三氯生、氯己定、柠檬 酸锌、硝酸银、铜、柠檬烯和西吡氯铵。在一些实施例中,另外的抗龋剂可包括氟离子或提供氟的组分如无机氟化盐。在一些实施例中,可包括可溶性碱金属盐,例如氟化钠、氟 化钾、氟硅酸钠、氟硅酸铵和单氟磷酸钠,还可以包括锡的氟化物如氟化亚锡以及氯化亚 锡。在一些实施例中,对口腔的护理和卫生具有有益效果(例如降低牙釉质的酸溶解性, 以及保护牙齿以防蛀)的含氟化合物也可作为成分被包括。其例子包括氟化钠、氟化亚锡、 氟化钾、氟化亚锡钾(SnF.sub.2-KF)、六氟锡酸钠、氯氟化亚锡、氟锆酸钠和单氟磷酸钠。 在一些实施例中,包括脲。
更多的例子被包括在下列美国专利和美国公开的专利申请中(为了所有的目的,将所 述专利和专利申请的内容以引用方式整体并入本文):Reynolds的美国专利第5,227,154 号、Greenberg的美国专利第5,378,131号、Luo等人的美国专利第6,846,500号、Luo等人 的美国专利第6,733,818号、Luo等人的美国专利第6,696,044号、Holme等人的美国专利第6,685,916号、Luo等人的美国专利第6,485,739号、Holme等人的美国专利第6,479,071号、Luo等人的美国专利第6,471,945号、Holme等人的美国专利公开第20050025721号、Gebreselassie等人的美国专利公开第2005008732以及Holme等人的美国专利公开第20040136928号。
活性成分
活性物通常指那些因其提供给消费者的期望的最终益处而被包括在递送系统和/或咀 嚼型胶基糖中的成分。在一些实施例中,活性物可包括药剂、营养物、保健品、草本剂、营养补充剂、药物、药品等等,以及其组合。
有用的药品的例子包括ace抑制剂、抗心绞痛药、抗心率不齐剂、抗哮喘剂、抗高胆固醇血症剂、镇痛剂、麻醉剂、抗痉挛剂、抗抑郁剂、抗糖尿病剂、抗腹泻制剂、解毒剂、 抗组胺剂、抗高血压药、消炎剂、抗脂质剂、抗躁狂剂、抗呕吐剂、抗中风剂、抗甲状腺 制剂、抗癌药、抗病毒剂、痤疮药、生物碱、氨基酸制剂、止咳剂、抗高尿酸血症药、抗 病毒药、合成代谢制剂、系统性和非系统性抗感染剂、抗肿瘤剂、抗帕金森症剂、抗风湿 剂、食欲刺激剂、生物响应改进剂、血液改进剂、骨代谢调节剂、心血管药剂、中枢神经 系统刺激剂、胆碱酯酶抑制剂、避孕药、解充血剂、膳食补充剂、多巴胺受体激动剂、子 宫内膜异位控制剂、酶、勃起障碍治疗剂(如目前以ViagraTM出售的柠檬酸西地那非)、 致育剂、肠胃药剂、顺势治疗剂、激素、高血钙症和低血钙症控制剂、免疫调节剂、免疫 抑制剂、偏头痛制剂、运动病治疗剂、肌肉松弛剂、肥胖控制剂、骨质疏松制剂、催产素、 副交感神经阻断剂、拟副交感神经剂、前列腺素、心理治疗剂、呼吸药剂、镇静剂、戒烟 辅助剂(如溴隐定或尼古丁)、交感神经抑制剂、震颤制剂、尿路药剂、血管扩张剂、轻 泻剂、抗酸剂、离子交换树脂、解热剂、食欲抑制剂、祛痰剂、抗焦虑剂、抗溃疡剂、消 炎物、冠状血管扩张剂、脑扩张剂、外围血管扩张剂、精神药剂、刺激剂、抗高血压药、 血管收缩剂、偏头痛治疗剂、抗生素、镇定剂、抗精神病剂、抗肿瘤药、抗凝血剂、抗血 栓药、催眠剂、止吐剂、抗呕吐剂、抗痉挛剂、神经肌肉药、高和低血糖症药剂、甲状腺 和抗甲状腺制剂、利尿剂、止痉挛剂、子宫弛缓剂(terine relaxant)、抗肥胖药、红血球生 成药、抗哮喘剂、咳嗽抑制剂、黏液溶解剂、DNA和基因修正药,以及其组合。
考虑用在一些实施例中的活性成分的例子可包括抗酸剂、H2拮抗剂和镇痛剂。例如, 抗酸剂配料可单独用碳酸钙成分或用碳酸钙成分与氢氧化镁和/或氢氧化铝组合来制备。 此外,抗酸剂可与H2-拮抗剂组合使用。
镇痛剂包括鸦片剂和鸦片衍生物,如OxycontinTM、布洛芬、阿司匹林、乙酰氨基酚,以及其组合,所述组合可选地包括咖啡因。
其它用于实施例中的药物活性成分可包括抗腹泻剂(如ImmodiumTMAD)、抗组胺剂、止咳剂、解充血剂、维生素以及口气清新剂。考虑用于本文中的还有抗焦虑剂如XanaxTM; 抗精神病剂如ClozarilTM和HaldolTM;非甾抗炎剂(NSAID’s)如布洛芬、萘普生钠、VoltarenTM和LodineTM;抗组胺剂如ClaritinTM、HismanalTM、RelafenTM和TavistTM;止吐剂如KytrilTM和CesametTM;支气管扩张剂如BentolinTM、ProventilTM;抗抑郁剂如ProzacTM、ZoloftTM和PaxilTM; 抗偏头痛剂如ImigraTM;ACE抑制剂如VasotecTM、CapotenTM和ZestrilTM;抗阿尔茨海默病 药剂如NicergolineTM;和CaH拮抗剂如ProcardiaTM、AdalatTM和CalanTM。
考虑用在本发明中的流行的H2拮抗剂包括西咪替丁、盐酸雷尼替丁、法莫替丁、尼扎替丁(nizatidien)、乙溴替丁、咪芬替丁、罗沙替丁、pisatidine和aceroxatidine。
活性的抗酸剂成分可包括但不限于下列物质:氢氧化铝、二羟基氨基乙酸铝、氨基乙 酸、磷酸铝、二羟铝碳酸钠、碳酸氢盐、铝酸铋、碳酸铋、碱式碳酸铋、碱式没食子酸铋、碱式硝酸铋、subsilysilate铋、碳酸钙、磷酸钙、柠檬酸离子(酸或盐)、氨基乙酸、水合 硫酸铝酸镁、镁铝水合物、铝硅酸镁、碳酸镁、甘氨酸镁、氢氧化镁、氧化镁、三硅酸镁、 牛奶固形物、一代或二代磷酸钙铝(aluminum mono-ordibasic calcium phosphate)、磷酸三钙、碳酸氢钾、酒石酸钠、碳酸氢钠、铝硅酸镁、酒石酸以及盐。
多种营养补充剂也可用作活性物组分,包括事实上任何维生素或矿物质在内。例如, 可使用维生素A、维生素C、维生素D、维生素E、维生素K、维生素B6、维生素B12、 硫胺素、核黄素、生物素、叶酸、烟酸、泛酸、钠、钾、钙、镁、磷、硫、氯、铁、铜、 碘、锌、硒、锰、胆碱、铬、钼、氟、钴,以及其组合。
可用作活性成分的营养补充剂的例子在美国专利申请公开第2003/0157213A1号、第 2003/0206993号和第2003/0099741A1号中阐明,为了所有的目的将所述专利公开以引用 方式整体并入本文。
各种草本剂也可用作活性成分,如那些具有各种药用或膳食补充剂性质的草本剂。草 本剂通常是可在医药上使用或用于调味的芳香植物或植物部分和/或其提取物。合适的草 本剂可单独地使用或以各种混合物使用。常用的草本剂包括紫锥菊、白毛莨、金盏草、迷 迭香、百里香、卡法胡椒、芦荟、血根草、葡萄柚种子提取物、黑毛莨、高丽参、瓜拉那(guarana)、蔓越桔、银杏、圣约翰草、月见草油、育亨宾树皮、绿茶、麻黄、玛卡、越桔、 黄体素,以及其组合。
泡腾系统成分
泡腾系统可包括一种或多种可食用酸和一种或多种可食用碱性材料。所述的一种或多 种可食用酸和一种或多种可食用碱性材料可一起反应以产生泡腾。
在一些实施例中,所述的一种或多种碱性材料可选自但不限于:碱金属碳酸盐、碱金 属碳酸氢盐、碱土金属碳酸盐、碱土金属碳酸氢盐,以及其组合。所述的一种或多种可食用酸可选自但不限于:柠檬酸、磷酸、酒石酸、苹果酸、抗坏血酸,以及其组合。在一些 实施例中,泡腾系统可包括一种或多种其它的成分,例如二氧化碳、口腔护理成分、风味 料等。
关于在胶基糖中使用泡腾系统的例子,参见2004年10月13日递交、题为“Effervescent Pressed Confectionery Tablet Compositions(泡腾的压制糖食片组合物)”的美国临时专利第 60/618,222号,为了所有的目的将所述专利申请的内容以引用方式整体并入本文。其它的 例子可在美国专利第6,235,318号中找到,为了所有的目的将所述专利的内容以引用方式 整体并入本文。
食欲抑制剂成分
食欲抑制剂可以是起到抑制消费食物愿望的作用的成分,如纤维和蛋白质。食欲抑制 剂还可包括苄非他明、安非拉酮、马吲哚、苯甲曲秦、芬特明、hoodia(P57)、OlibraTM、麻黄、咖啡因,以及其组合。食欲抑制剂也经由以下商品名为人所知:AdipexTM、AdipostTM、BontrilTMPDM、BontrilTMSlow Release、DidrexTM、FastinTM、IonaminTM、MazanorTM、MelfiatTM、 ObenixTM、PhendietTM、Phendiet-105TM、PhentercotTM、PhentrideTM、PlegineTM、Prelu-2TM、Pro-FastTM、 PT 105TM、SanorexTM、TenuateTM、SanorexTM、TenuateTM、TenuateDospanTM、Tepanil Ten-TabTM、TeramineTM和ZantrylTM。这些和其它的合适的食欲抑制剂在以下美国专利中进一步描述, 所述专利全部以引用方式整体并入本文:Portman的美国专利第6,838,431号、Portman的 美国专利第6,716,815号、Portman的美国专利第6,558,690号、Portman的美国专利第 6,468,962号、Portman的美国专利第6,436,899号。
微量营养素成分
微量营养素可包括对生物体的营养健康有影响的材料,尽管其为了达到期望的效果而 被生物体需要的量相对于大量营养素(例如蛋白质、碳水化合物和脂肪)来说要小。微量 营养素可包括但不限于维生素、矿物质、酶、植物化学品、抗氧化剂,以及其组合。
在一些实施例中,维生素可包括脂溶性维生素如维生素A、维生素D、维生素E、维生素K,以及其组合。在一些实施例中,维生素可包括水溶性维生素如维生素C(抗坏血 酸)、B族维生素(硫胺素或B1、核黄素或B2、烟酸或B3、吡哆醇或B6、叶酸或B9、 氰钴胺或B12、泛酸、生物素),以及其组合。
在一些实施例中,矿物质可包括但不限于钠、镁、铬、碘、铁、锰、钙、铜、氟化物、钾、磷、钼、硒、锌,以及其组合。
在一些实施例中,微量营养素可包括但不限于L-肉碱、胆碱、辅酶Q10、α-硫辛酸、ω-3脂肪酸、胃蛋白酶、植酸酶、胰蛋白酶、脂肪酶、蛋白酶、纤维素酶,以及其组合。
在一些实施例中,植物化学品可包括但不限于类胡萝卜素、叶绿素、叶绿酸、纤维、类黄酮、花青素、矢车菊素、花翠素、锦葵色素、天竺葵色素、芍药花青素、矮牵牛苷配 基、黄烷醇、儿茶酚、表儿茶酚、表没食子儿茶素、表没食子儿茶素没食子酸酯(EGCG)、 茶黄素、茶红素、原花青素、黄酮醇、槲皮素、山奈素、杨梅黄酮、异鼠李素、 flavononeshesperetin、柚皮素、圣草酚、蜜橘素、黄酮类、芹菜苷配基、木犀草素、木酚 素、植物雌激素、白藜芦醇、异黄酮、大豆黄素、染料木黄酮、黄豆黄素、大豆异黄酮, 以及其组合。
口腔润湿成分
口腔湿润剂可包括但不限于唾液刺激剂如酸和盐及其组合。在一些实施例中,酸可包 括乙酸、己二酸、抗坏血酸、丁酸、柠檬酸、甲酸、富马酸、葡糖酸、乳酸、磷酸、苹果 酸、草酸、琥珀酸、酒石酸,以及其组合。在一些实施例中,盐可包括氯化钠、氯化钙、 氯化钾、氯化镁、海盐、柠檬酸钠,以及其组合。
口腔湿润剂还可包括与水化合并且可粘附在口腔表面以提供口腔湿润感觉的水性胶 体材料。水性胶体材料可包括天然产生的材料,如植物渗出液、种子糖食和海藻提取物, 或水性胶体材料可以是化学改性的材料,如纤维素、淀粉或天然糖食衍生物。在一些实施 例中,水性胶体材料可包括果胶、阿拉伯树胶、金合欢树胶、海藻酸盐、琼脂、角叉菜胶、瓜尔胶、黄原胶、刺槐豆胶、明胶、结冷胶、半乳甘露聚糖、黄芪胶、刺梧桐树胶、凝乳 聚糖、魔芋胶、脱乙酰壳多糖、木葡聚糖、β-葡聚糖、红藻胶、茄替胶(gum ghatti)、罗望 子胶(tamarin)、细菌胶,以及其组合。另外,在一些实施例中,可包括改性的天然胶,如 海藻酸丙二醇酯、羧甲基刺槐豆胶、低甲氧基果胶,以及它们的组合。在一些实施例中, 可包括改性纤维素,如微晶纤维素、羧甲基纤维素(CMC)、甲基纤维素(MC)、羟丙基甲基 纤维素(HPCM)以及羟丙基纤维素(MPC),以及其组合。
类似地,可包括可提供口腔水化(mouth hydration)感觉的保湿剂。这样的保湿剂可 包括但不限于甘油、山梨糖醇、聚乙二醇、赤藓糖醇及木糖醇。另外,在一些实施例中,脂肪可提供口腔湿润感觉。这样的脂肪可包括中链三甘油酯、植物油、鱼油、矿物油,以 及其组合。
咽喉护理成分
咽喉舒缓成分可包括镇痛剂、麻醉剂、缓和剂、消毒剂,以及其组合。在一些实施例中,镇痛剂/麻醉剂可包括薄荷醇、苯酚、己雷琐辛、苯佐卡因、盐酸达克罗宁、苯甲醇、 水杨醇,以及其组合。在一些实施方案中,缓和剂可包括但不限于赤榆皮、果胶、明胶, 以及其组合。在一些实施例中,消毒剂成分可包括西吡氯铵、度米芬、地喹氯铵,以及其 组合。
在一些实施例中,可包括止咳成分如盐酸氯苯达诺、可待因、磷酸可待因、硫酸可待 因、右美沙芬、氢溴酸右美沙芬、枸橼酸苯海拉明和盐酸苯海拉明,以及其组合。
在一些实施例中,可包括咽喉舒缓剂,如蜂蜜、蜂胶、芦荟、甘油、薄荷醇,以及其组合。在另外其它的实施例中,可包括咳嗽抑制剂。这样的咳嗽抑制剂可分成两组:改变 痰液的稠度或产生量的咳嗽抑制剂,如粘液溶解剂和祛痰剂;以及抑制咳嗽反射的咳嗽抑 制剂,如可待因(麻醉性咳嗽抑制剂)、抗组胺剂、右美沙芬及异丙肾上腺素(非麻醉性 咳嗽抑制剂)。在一些实施例中,可包括来自任一组或两组的成分。
在另外其它的实施例中,止咳剂可包括但不限于由可待因、右美沙芬、右啡烷、苯海 拉明、氢可酮、诺斯卡品、羟考酮、喷托维林,以及其组合组成的组。在一些实施例中, 抗组胺剂可包括但不限于:阿伐斯汀、阿扎他定、溴苯那敏、氯苯那敏、氯马斯汀、赛庚 啶、右溴苯那敏、茶苯海明、苯海拉明、多西拉敏、羟嗪、氯苯甲嗪、苯茚胺、苯托沙敏、 普鲁米近、美吡拉敏、曲吡那敏、曲普利啶,以及其组合。在一些实施例中,非镇定性抗 组胺剂可包括但不限于阿司咪唑、西替利嗪、依巴斯汀、非索非那定、氯雷他定(loratidine)、 特非那定,以及其组合。
在一些实施例中,祛痰剂可包括但不限于氯化铵、愈创甘油醚、吐根流浸膏、碘化钾, 以及其组合。在一些实施例中,粘液溶解剂可包括但不限于乙酰半胱氨酸、氨溴索、溴己 新,以及其组合。在一些实施例中,镇痛剂、解热剂和消炎剂可包括但不限于对乙酰氨基酚、阿司匹林、双氯芬酸、二氟尼柳、依托度酸、非诺洛芬、氟比洛芬、布洛芬、酮洛芬、 酮咯酸、萘丁美酮、萘普生、吡罗昔康、咖啡因,以及其混合物。在一些实施例中,局部 麻醉剂可包括但不限于利多卡因、苯佐卡因、苯酚、达克罗宁、苯佐那酯,以及其混合物。
在一些实施例中,可包括鼻解充血剂和提供鼻清理感觉的成分。在一些实施例中,鼻 解充血剂可包括但不限于苯丙醇胺、伪麻黄碱、麻黄碱、去氧肾上腺素、羟甲唑啉,以及其组合。在一些实施例中,提供鼻清理感觉的成分可包括但不限于薄荷醇、樟脑、冰片、 麻黄碱、桉树油、胡椒薄荷油、水杨酸甲酯、乙酸冰片酯、薰衣草精油、青芥辣(wasabi) 提取物、辣根提取物,以及其组合。在一些实施例中,鼻清理感觉可由香精油、得自木料、 糖食、花和其它植物的提取物、树脂、动物分泌物以及合成芳香材料提供。
在一些实施例中,可选的成分或功能性成分可包括口气清新剂、牙齿护理组分、活性 物、草本剂、泡腾系统、食欲抑制剂、维生素、微量营养剂、口腔湿润组分、咽喉护理组分、精力增进剂、专注力增进剂,以及其组合。
在一些实施例中,调释组分包括至少一种选自包括风味物、甜味剂、感知物、口气清 新剂、牙齿护理组分、活性物、草本剂、泡腾系统、食欲抑制剂、增强剂、食品酸度剂、 微量营养剂、口腔湿润组分、咽喉护理组分,以及其组合的组的成分。这些成分可以是被 包封形式,也可以是游离形式,或两者都有。
完成的咀嚼型胶基糖组合物的实施例
表1:咀嚼型胶基糖组合物
*胶基糖基料可包括3重量%至11重量%的填充剂,例如滑石、磷酸二钙以及碳酸钙(胶基糖基料中的填充剂的 量是基于胶基糖区(region)组合物的重量百分数,例如,在上文的组合物Y-FF中,如果胶基糖区组合物包括5%的填充 剂,则胶基糖基料的量将比表中所列举的范围小5%,即从23至37%)
用于咀嚼型胶基糖的组合物如下进行制备:首先将滑石(在存在的情况下)与胶基糖 基料在约85℃加热条件下进行组合。然后,将该组合与增量甜味剂、卵磷脂以及甜味剂糖浆混合六分钟。添加包括风味物和清凉剂的预混物的风味物共混物并混合1分钟。最后,添加酸和强力甜味剂并混合5分钟。
除了以上提到的各种咀嚼型胶基糖,应该理解的是,以下讨论的系统和方法可用于形 成和定型糖食或糖果、胶基糖成分与糖食或糖果成分的组合以及胶基糖与糖食或糖果的组 合,如在美国专利公开第2008/0166449号、国际公开第WO 2011/044373号和国际公开第 WO 2010/092480号(这些专利文件的教导和公开内容,只要不与本公开相矛盾,则以引 用方式整体并入本文)中所公开。
示例性的系统和方法
图1示出用于形成具有起伏的表面的咀嚼型胶基糖的一个示例性系统10。概括地说, 系统10包括形成或定型工位12,所述形成或定型工位包括第一辊14和第二辊16。这些辊14和16能够将所述咀嚼型胶基糖定型为期望的厚度。在美国申请第13/522,767号中也充分描述和讨论了经由这样的辊将咀嚼型胶基糖定型为期望的厚度,该申请的教导和公开内容以引用方式整体并入本文。另外,辊14和16能够在所述咀嚼型胶基糖的表面中创建 厚度变化(定型和创建厚度变化这两方面都在下文中作更详细的讨论)。由于在第二辊 14中所示的隆起部20的构型(尤其请参见图1A),所述胶基糖中的厚度变化在胶基糖流 过工位12的方向上发生。换句话说,所创建的起伏横跨所述胶基糖的宽度13。在以下讨 论了经由示例性的系统10进行的胶基糖定型之后,将更详细地讨论厚度变化的形成。
系统10可用来形成(以及冷却或加热)包括各种成分的咀嚼型胶基糖。任何常规的混合机都可用来混合所述咀嚼型胶基糖,尽管所使用的混合机的类型可能影响定型工位12的进料特性。例如,可采用不同类型的预调理和低剪切挤出机来修改原始的(raw)混合机输出并产生规则流和/或连续流。在任一情形中,都考虑了定型工位12可容易地与业内采用的各种混合系统一起使用。
示例性的混合系统21在图1中示出,取决于期望的咀嚼型胶基糖的配方,所述混合系统可包括一个或多个混合机。取决于所混合的成分或所述成分被混合的状况,所述一个或多个混合机可提供不同类型的混合。本文考虑了诸如但不限于分布式混合机和分散式混合机的混合机。分散式混合典型地是高剪切混合,能将组合物内的各个成分及成分聚集体打碎成更小的块。分布式混合典型地涉及比分散式混合低的剪切力,并且被用来使各个成分遍及所述组合物分布以提供更均匀的组合物。分散式混合和分布式混合在美国专利第5,562,936号中更为透彻地进行了描述和讨论,该专利的教导和公开内容以引用方式整体并入本文。
混合系统21的混合机可为连续式混合机或分批式混合机。本文使用的“连续式混合机” (在本文中也可称为“连续式加工机”)是这样的加工设备:用来制备流出物(effluent)的各 种成分被基本上连续地进料到所述设备中,同时那些成分被混合并且从所述混合系统移除 或排出。例如,在连续式混合挤出机中,各成分基本上连续地通过各个上游和下游的进料 口被引入,而螺杆、桨叶、销、桨板或其它混合元件一直在所述系统内传送和混合所述混 合物。在所述挤出机的下游部分,所述料团的被完全地或部分地组合的下游部分凭借所述 料团被基本上连续地或被连续地传送的力而从所述挤出机排出。
连续式混合机可提供分散式混合、分布式混合或分散式混合和分布式混合二者的组 合。例如,挤出机形式的连续式混合机可具有全部的分散式混合元件、全部的分布式混合 元件或分散式混合元件和分布式混合元件的组合。由于混合胶基糖组合物的特性和要求, 分散式混合元件典型地位于分布式混合元件的上游,然而,根据本发明的连续式混合机不 限于这种布置方式。
本文使用的“分批式混合机”(在本文中也称为“批式加工机”)是这样的加工设备:其 将制备好的组合物一次性从设备中排出,或在间歇的时间段以至少分立的非连续部分从设 备中排出。典型地,用来制备所述组合物的各个成分或各个成分的部分被一次性基本上全 部进料到所述设备,或以分立的量按预定的时间顺序进料到所述设备。添加到分批式混合 机的各个成分可在整个混合周期的不同时间添加,从而一些成分具有基本上等于所述混合 周期的整个时长的停留时间,而其它成分具有仅为所述混合周期的全部时长的一部分的停 留时间。进一步地,对于在整个混合周期中用于不同目的的单个成分,其不同的分立部分 可在整个混合过程中的不同时间添加。例如,一种成分可用来便利于将弹性体进行复合, 并且可用作增量剂。这样的成分可分出第一部分在混合周期开始时添加,从而所述第一部 分的停留时间等于整个混合时间,而所述同一成分的第二部分可在混合周期内稍后添加, 从而所述第二部分的停留时间小于整个混合时间。
分批式混合机典型地将提供分散式混合或分布式混合。用于实施本发明的分批式混合 机可被构造成提供分散式混合和分布式混合二者。例如,考虑了包括内部桨叶的釜式混合 机可经由修改桨叶的节距或取向而被构造成在分散式混合和分布式混合之间转换。作为另 一种选择,釜式混合机可包括多套桨叶,从而一套被构造成用于分散式混合,而另一套被 构造成用于分布式混合。考虑了混合机最可能每次仅使用一套桨叶以每次提供一种类型的 混合。
在一些实施例中,胶基糖混合系统21可包括一个连续式混合机或一个分批式混合机。 在其它的实施例中,胶基糖混合系统21可包括串联布置和/或并联布置的一个或多个连续 式混合机和/或一个或多个批式混合机。各种并联和串联混合系统布置方式在被转让给本 受让人的美国专利申请第12/338,428号和第12/338,682号中有描述,所述申请的公开内容 以引用方式整体并入本文。
现更具体地参见图1中示出的实施例,来自于胶基糖混合系统21的咀嚼型胶基糖输 出22可为通常不规则或换句话说非均匀厚度的胶基糖料团。胶基糖定型工位12可加工弹 性体或成品胶基糖或介于弹性体和成品胶基糖之间的包括任何数目的胶基糖基料成分和/ 或胶基糖成分的任何胶基糖结构。尽管咀嚼型胶基糖输出22可为任何类型或阶段的咀嚼 型胶基糖,但在此实施例中,咀嚼型胶基糖输出22为成品胶基糖。取决于咀嚼型胶基糖的配方,非均匀的咀嚼型胶基糖输出22可作为胶基糖料团24被直接地在料斗23进料到 定型工位12中。定型工位12然后形成和定型出具有期望(尽管可变的)厚度的基本上扁 平的胶基糖片材26。然而,如在图1的示例性实施例中所示,可将非均匀的咀嚼型胶基 糖输出22进一步加工成稍微均匀的形状或宽度,然后再作为胶基糖料团24进入胶基糖定 型工位12。尽管不是在定型工位12中进行定型所必要的,但这个进一步加工成稍微均匀 的形状可经由例如但不限于低剪切挤出机28的设备完成,所述低剪切挤出机将所述咀嚼 型胶基糖预形成为条块30。
相对于更为典型的定型式挤出机和/或用于经由渐进地减少厚度来将胶基糖进行定型 的多个辊,如图1中所示,胶基糖定型工位12仅包括两个形成/定型辊。在使用胶基糖定 型工位12来形成连续的片材26时,不再需要强行地使胶基糖挤出通过确定宽度的矩形孔 口。结果是,一个可实现的优点是施加在胶基糖上的剪切力可显著降低。进一步的结果是, 某些剪切敏感成分可保留得更加完整,使得要么所生成的产品可在最终产品中具有更多完 整的剪切敏感成分,要么在胶基糖混合操作期间需要添加较小量的剪切敏感成分,从而有 可能节约成本或为消费者提供增强的咀嚼型胶基糖特性。考虑到了剪切和温度敏感成分, 如上文中描述的那些,包括特定的被包封的甜味剂、风味物以及各种活性药物成分在内, 会特别受益于所述可能较低剪切的加工。
如上提到,胶基糖定型工位12包括第一辊14和第二辊16。辊14和16是外部驱动的,例如经由可操作地连接的马达来驱动。在一个示例性的实施例中,辊14和16各自提 供有马达,使得每个辊的旋转速度可独立地进行控制。
料斗23可用于上游波动控制、容量和进料控制。料斗23限制、积累胶基糖料团24并将所述胶基糖料团进料到通常在辊14和16之间的入口区。料斗23可被配置为直接接 收呈条块的形式的咀嚼型胶基糖输出22,和/或接收另一稍微均匀的具有各种卷材宽度的 咀嚼型胶基糖的卷材。无论料斗23以何种形式接收咀嚼型胶基糖输出22,这个输出都作 为非均匀地成型的胶基糖料团24在料斗23中积累。辊14和16的宽度可根据胶基糖片材 26的期望宽度进行调整,因为胶基糖片材26通常将伸展到辊14和16的宽度。在一个示 例性的实施例中,上和下辊14和16被配置成适应宽度为约25mm至1m之间或可能更宽 的胶基糖片材26。可能期望具有宽度大于约0.6m的较宽的胶基糖片材,以便能够提供大 的胶基糖料团体积,使得可以较低的速度操作所述料团而同时又产生充足的输出。
进料到所述料斗中的胶基糖料团24经由重力朝料斗输出34落下。设置在料斗23内的进料辊可帮助这个经由重力通过料斗进行的落下。
胶基糖料团24然后被上辊14导向下辊16,其中相反旋转的上辊14和下辊16将胶基糖料团24在辊14和16之间拉拔,以将胶基糖料团24形成和定型为胶基糖片材26。
如图1的示例性实施例中所示,上辊14具有垂直轴线40,而下辊16具有垂直轴线41。这些轴线40、41被布置成使得上和下辊14和16在水平方向上偏置。如图中所示, 辊14和16在垂直方向上也偏置。此外,上辊14和下辊16被布置成使得在辊14和16之 间存在间隔或间隙42。辊对14和16及间隔42被配置成施加压缩或变形力到胶基糖料团 24上,以形成具有与间隙42的高度相应的厚度的胶基糖片材26。如下文中将更详细地讨 论,在间隙42的至少部分长度上,间隙42的高度可根据上和下辊14和16的旋转而变化, 这个高度变化是因为隆起部20在间隙42中的交替存在而发生的。
随着在上辊14的旋转的各个阶段胶基糖料团24被拉拔通过间隙42(所述间隙可窄至0.1mm,或在某些实施例中甚至为零间隙),胶基糖料团24料团在辊14和16之间被 变形,这个变形/定型基本上是扩展的(extensional)。在即将被辊14和16进行定型之前(因 而在刚排出料斗23之后或在排出所述料斗时),胶基糖料团24是基本上未成型的。应说 明的是,“未成型的”胶基糖料团可定义为任何在其当前状态下未经由挤出、变形或任何其 它手段进行定型或形成的料团,尽管所述胶基糖料团可能在处于这个当前状态之前已用这 种方式进行了定型或形成。换句话说,胶基糖片材26的尺寸是独立于未成型的胶基糖料 团24的形状和尺寸创建的。但是应说明的是,离开料斗23的物料、间隙42和片材26的 宽度可全部基本上相同。另外,当胶基糖料团24离开料斗23时,胶基糖料团24的一个 示例性实施例可包括大于3倍的胶基糖片材26、更具体地10至70倍的胶基糖片材26的 厚度尺寸。在一个示例性的实施例中,紧邻间隙42的上游处的胶基糖料团24的厚度为 500至800mm,而紧邻间隙42的下游处的胶基糖片材26的厚度为0.1至60mm,更具体 地0.3至10mm。
现在暂时将关于上辊14上的隆起部20的讨论搁置一边,应说明的是辊14和16可被构造成具有彼此不同的直径,这取决于所形成的胶基糖的物理特性、离开间隙42的胶基 糖片材26的期望厚度和宽度以及离开间隙42的胶基糖片材26的期望温度。在图1中所 示的示例性实施例中,下辊16具有比上辊14大的直径。但是,在其它实施例中,上辊可 具有比下辊大的直径,或所述辊可具有相同的直径。优选地,下辊16具有约0.5m至3m 之间的直径和约0.6m至1.3m之间的宽度;上辊14具有约0.25m至1m之间的直径,而 宽度则相似。如图所示,优选地,携带胶基糖旋转几度的辊在直径上比为了某种冷却/加 热和/或硬化(setting)效果的其它辊相对较大,如稍后所讨论。虽然更窄的辊也是可能的, 但具有约0.6m至1.3m之间或更宽的宽度的辊提供了生产在宽度上与辊大约相同、典型地 至少稍窄的胶基糖带(ribbon)或片材的机会。
应认识到,取决于胶基糖产品的期望厚度,可经由调整辊14和16的相对垂直位置来 调整所述间隙的高度。辊14和16可被配置为具有任何期望的致动装置,如但不限于伺服机构,以控制辊14和16相对于彼此的垂直位置,从而调整间隙42。
料斗23可被布置成具有锥形的外壁,所述外壁邻接下辊16而与之具有非常小的间隙, 以便下辊16可以旋转。类似地,料斗23的外壁邻接上辊14而与之具有非常小的间隙。锥形的外壁被构造成用来将胶基糖料团24导向间隙42。作为另一种选择,料斗23的壁 可直接搁在辊14和16上。
上辊14和下辊16可以各种旋转速度运行。辊14和16可以相同的旋转速度或不同的旋转速度运行。辊14和16各自的旋转速度可根据输入的胶基糖的物理特性和期望的经由辊14和16的传热量来选择。在一个实施例中,被构造成具有比上辊14大的直径的下辊 16以比所述较小的上辊14低的旋转速度运行。此外,可调整辊14和16的相对旋转速度 以生产期望质量的胶基糖片材26,如表面特性、厚度公差、温度等。
在一个示例性实施例中,辊14和16还可被配置成以相同的线速度或以不同的线速度 运行,所述线速度是在所述辊的表面的切线上测量的。在一个实施例中,将一个辊设定在 恒定的线速度,而另一个辊的线速度可在所述辊的恒定线速度的±30%之间变化。例如, 可将下辊16的线速度设定在3m/min,而上辊14的线速度控制在2.1m/min至3.9m/min之间。在这样的实施例中,上辊14的线速度在设定范围内进行调整,以实现胶基糖的较光 滑的表面和使胶基糖的起皱最小化。作为另一种选择,可将上辊14设定在恒定的线速度, 而下辊16的线速度可在期望的范围内进行控制。取决于胶基糖的特性和期望的变化厚度 以及胶基糖片材26的宽度,一个辊的线速度可相对于另一个辊的线速度在±40%、±30%、±20%或±10%的范围内变化,以使预期的光滑度最大化和使胶基糖表面上的起皱和其它非 预期的不规则最小化。在一个不同的实施例中,可将相互间具有不同直径的辊14和16配置成以相同的线速度(例如,在切线上的速度相同;但角速度不同,因为较小的辊旋转得 较快)运行。
设计好辊14和16的尺寸配置和材料以及辊14和16的支撑结构,以使辊14和16的偏斜最小化或消除。图8是固定到结构框架50的辊14和16的卷材横向视图(cross-webview) 的示意图。如所示,上辊14经由轴52安装在结构框架50上。类似地,下辊16经由轴 54安装在结构框架50上。
如上所提及,定型工位12的辊14和16同时负责将胶基糖料团24定型为具有期望的尺寸的胶基糖片材26和在胶基糖片材26的表面中创建厚度变化。在图1和1A中所示的 示例性实施例中,这个厚度变化是经由沿下辊14轴向设置的隆起部20创建的,即在片材26在间隙42内被定型为期望的厚度(约0.3mm至10mm之间)的同时,所述隆起部在片 材26中产生所述变化或起伏。
事实上,并且如图1A和1B中最好地显示,上辊14包括最小直径56和最大直径58(经由隆起部20),这将在胶基糖片材26中的最大高度62中赋予最小高度60(经由来 自隆起部20的压力所造成的片材26的下表面66中的凹入部64)。在图1和1A中所示 的示例性实施例中,辊14的直径变化(经由隆起部20)在纵向或料流方向68上创建厚 度变化,这个变化经由凹入部64和非凹入部部分在片材26的相对下表面66中显示,因 为上辊14赋予所述片材的下表面以厚度变化而下辊16赋予所述片材的上表面67以厚度 变化。最小高度60可为任何相对于胶基糖片材26的其余部分而言的、能够保持片材26 完整的高度,尽管在一个示例性实施例中,最小高度60可比最大高度62小10%至30% 或大约20%。在另一个示例性的实施例中,最小高度60和最大高度62还可经由沿着下(和 /或上)表面66的正弦曲线图案连接,其中最大高度62布置在波的各个峰,而最小高度 60布置在波之间的各个谷底。除了上辊14以外,下辊16可还包括或作为另一种选择包 括会将类似的凹入部63赋予到片材26的上表面67中的隆起部20。显示这样的辊14和 16及所得的片材26的实施例分别在图2A和2B中显示。虽然这些图显示在辊14和16 上都有隆起部20(因而在片材26的两个表面上都有凹入部),但系统10显然可被配置 成仅具有带隆起部的底辊,这将导致片材26具有基本上平坦的下表面和锯齿状(indented) 的上表面。
当然,辊14和16中的一者或两者可包括除图1A中所示的“U”形隆起部20以外的许多类型的直径变化,这些变化在胶基糖片材46的上和/或下表面中产生各种起伏。例如, 如果使用如附图标记20所表示的那些隆起部来创建变化,则这些隆起部可为“U”形的(如 同图1A和2A中)、“V”形的、方形的,或被构造成包括任何其它符合期望的形状并在片 材26中创建相应地成型的凹入部。此外,这些隆起部可与设置有它们的辊的其余部分一 起成为一体构造,或以任何不会使辊破坏性地变形的方式可拆卸地附接(经由螺纹结合、 焊接、铆接、粘合剂等附接)。经由这样的隆起部在片材的表面中创建的凹入部或通道还 可在工位12的下游填充以另一胶基糖或糖食组合物。
如图3A和3B中所示,辊还可包括经由在辊中轴向延伸的通道70所致的直径变化。这样的通道70创建最小直径72(经由通道70的基底)和最大直径74,这将在胶基糖片 材26中的最小高度80中赋予最大高度76(经由通道70所创建的胶基糖隆起部78)。虽 然这些通道70在图3A中仅显示于一个辊中,并且胶基糖隆起部78在图3B中仅显示在 一个表面上,但这样的通道70显然可在两个辊中提供或只是在对向的那个辊中提供,这 会分别地在胶基糖片材26的两个表面上或只在所述胶基糖片材的对向的那个表面上创建 胶基糖隆起部78。辊通道70(如同隆起部20)可为“U”形的(如同图3A中)、“V”形的、 方形的,或被构造成包括任何其它符合期望的形状并在片材26中创建相应地成型的胶基 糖隆起部。同样,最小高度80可为任何相对于胶基糖片材26的其余部分(即胶基糖拱起 区域(ride area))而言的、能够保持片材26完整的高度,尽管在一个示例性的实施例中, 最小高度80可比最大高度76小10%至30%或大约20%。在另一个示例性的实施例中, 最小高度80和最大高度76还可经由沿着下和/或上表面的正弦曲线图案连接,其中最大 高度76布置在波的各个峰,而最小高度80布置在波之间的各个谷底。
经由通道70而包括直径变化的辊可在接触胶基糖料团24并将其定型为胶基糖片材 26之前填充以期望的胶基糖或糖食组合物。随着胶基糖料团24被穿过间隙42,通道70中的该胶基糖或糖果材料可在胶基糖片材26形成过程中被设置在所述胶基糖片材上,其中使用机械剥离装置或材料剥离剂帮助从通道70移除所述胶基糖或糖果材料以便设置在片材26上。如图3C中显示,这个胶基糖或糖果材料的隆起部81因此会在所得的片材26 中创建厚度变化。
以上讨论的辊隆起部20或通道70可被设置成相互间相隔均匀的距离(从而在片材26中产生均匀间隔的厚度变化),其中每个隆起部/通道具有相同的形状(从而在片材26 中产生均匀成型的厚度变化)。辊隆起部20或通道70还可被设置成相互间相隔非均匀的 距离(从而在片材26中产生非均匀间隔的厚度变化),其中至少一些隆起部/通道具有不 同的形状(从而在片材26中产生非均匀成型的厚度变化)。
此外,隆起部20或通道70可沿着辊14和16之一者或两者轴向延伸,使得所述隆起部/通道创建连续地或不连续地延伸跨片材26的整个宽度的厚度变化。具有这样的连续或不连续的隆起部20(或通道,作为另一种选择)的辊的例子分别在图4A和4B中显示。 类似地,隆起部20或通道70可沿着辊14和16之一者或两者轴向延伸,使得所述隆起部 /通道创建不延伸跨片材26的整个连续或不连续的宽度的厚度变化。具有这样的连续或不 连续的隆起部20(或通道,作为另一种选择)的辊的例子分别在图5A和5B中显示。
隆起部20和通道70两者还可在一个或两个辊中一起使用。在一个或两个辊上以交替 方式使用这样的隆起部和通道,会导致在胶基糖片材26的一个或两个表面创建各种各样 的波形图案。
虽然所有上述实施例都涉及在将胶基糖片材26定型为处于或接近其最终尺寸的厚度 (例如约0.3mm至10mm)的同时在片材26中形成厚度变化,但应认识到,当在料流方 向68上形成厚度变化时,这样的同时定型不是必要的。事实上,欲经由工位12形成的具 有厚度变化的咀嚼型胶基糖组合物可为这样的咀嚼型胶基糖片材26:其在到达将经由以 上讨论的实施例赋予厚度变化的(一个或多个)辊之前,已经在非通道和非隆起部区域中 处于或接近其最终厚度尺寸。
另外,并且如图6A和6B中所示,辊14和16之一者或两者可包括被配置成在离开(away from)料流方向68的方向上在胶基糖片材26中创建厚度变化的直径变化。例如,辊14和16之一者或两者可包括隆起部86,所述隆起部环绕所述辊的圆周,并在片材26的 (一个或多个)表面中创建跨片材的长度发生并基本上垂直于所述料流方向68的凹入部88。类似于以上讨论的料流方向实施例,所述辊的导致在离开料流方向68的方向上出现 片材厚度变化的直径变化可为“U”形的、“V”形的、方形的,或被构造成包括任何其它符合 期望的形状并在片材26中创建相应地成型的胶基糖隆起部和/或通道,同时考虑了在辊14 和16之一者或两者的整个或部分周长上有连续或不连续的延伸部(extent),并且在形状和 距离两方面也有均匀性或非均匀性。在离开料流方向68的方向上所形成的片材通道和/或 在离开料流方向68的方向上形成隆起部的辊通道,可按照与以上所讨论相同方式填充以 其它胶基糖或糖食组合物。另外,在离开料流方向68的方向上形成厚度变化的辊隆起部 和/或通道,可作为在料流方向68上形成厚度变化的隆起部和/或通道的补充或替代而被包 括在辊14和16之一者或两者。
本文还考虑了可经由辊14和16的至少一者在料流方向68上和/或在离开料流方向68 的方向上在片材26中创建的各种其它的起伏效果。一种这样的效果涉及经由如图9A中所 示的辊16的辊所形成的、如图9B中所示的胶基糖片材26的压纹(embossing)200。参见图9A和9B,辊14和16之一者或两者可包括被配置成在料流方向68上和在离开料流方 向68的方向上都在胶基糖片材26中创建压纹厚度变化的直径变化。例如,辊14和16之 一者或两者可包括压纹凸出部202,并在片材26的表面(一个或多个)中创建压纹凹入 部204。类似于以上讨论的实施例,所述辊的导致压纹厚度变化的直径变化可为“U”形的、 “V”形的、方形的辊凹入部和/或凸出部202,或被构造成包括任何其它符合期望的形状并 在片材26中创建相应地成型的压纹凹陷部204和/或压纹凸出部(如经由(一个或多个) 辊中的凹陷部)。这些凹陷部和/或凸出部在料流方向68上和/或基本上垂直于料流方向 68的方向上可对齐或可不对齐,并且还考虑了在形状和距离两方面也有均匀性或非均匀 性。压纹凹陷部或凸出部也可包括小于胶基糖片材26的最终剩余厚度的20%的深度或高 度。在片材26中形成的压纹凹陷部204可按照与以上讨论相同的方式进一步填充以其它 胶基糖或糖食组合物。
另一种效果涉及经由如图10A和10B中所示的辊16的辊来产生如图10C和10D中 所示的胶基糖片材26中的形状300。参见图10A、10B、10C和10D,辊14和16之一者 或两者可包括这样的直径变化:所述直径变化被构造成经由延伸出或延伸入辊14和16之 一者或两者的裁切结构(cut out structure)304a和304b来划定出呈任何形状302的胶基糖块 301(所述形状如但不限于圆形、正方形、矩形、三角形、星形或图10C和10D中所示的 闪电形状)。
例如,并且参见图10A和10C,辊14和16之一者或两者可包括裁切凹入部304a, 其中当所述(一个或多个)辊的非凹入部在间隙42中时,配备有这些凹入部304a的辊14 和16之间的间隙42(未显示)可为零间隙或接近零间隙。经由包括这样的辊的系统,凹 入部304a可要么完全从片材26切出成型块301(如果非凹入部区域处的间隙42为零间隙 的话),要么在块301和片材26之间留下非常薄的卷材303(如果非凹入部区域处的所 述间隙为接近零间隙的话,经由具有接近零间隙的间隙42形成的片材在图10C中示出)。 在一个示例性的实施例中,各块301之间的卷材区域303可包括小于胶基糖块301的厚度 的30%的厚度。可经由涉及分离设备/系统如但不限于卷材切割设备(例如围绕块301的 周边切割的刀片或小甜饼切割设备)和/或卷材冷却和断裂系统的方法,将卷材303与块 301断裂和/或修剪开。
参见图10B和10D,辊14和16之一者或两者还可包括划定出成型空腔306的成型隆起部304b,其中当所述(一个或多个)辊的隆起部在间隙42中时,配备有这些成型隆起 部304b的辊14和16之间的间隙42(未显示)可为零间隙或接近零间隙。经由包括这样 的辊的系统,成型隆起部304b和由隆起部304b划定出的空腔306可要么完全从片材26 切出成型块301(如果隆起部区域处的间隙42为零间隙的话),要么在块301和片材26 之间留下非常薄的卷材303(如果隆起部区域处的所述间隙为接近零间隙的话)。在一个 示例性的实施例中,各块301之间的卷材区域303可包括小于胶基糖块301的厚度的30% 的厚度。可经由涉及分离设备/系统如但不限于卷材切割设备(例如围绕块301的周边切 割的刀片或小甜饼切割设备(类似于隆起部304b))和/或卷材冷却和断裂系统的方法, 将卷材303与块301断裂和/或修剪开。
现参见图7,其中示出了将第一形成工位102与第二形成工位104串联的多层胶基糖 系统100。对于形成工位102和104每一者,该系统100包括系统10的上文所讨论的特 征的全部,第一形成工位102和第二形成工位104都基本上与上文讨论的形成工位12相 同。也就是说,针对工位12的辊14和16在上文中讨论并且在图1-6B和9A-10D中参照 的每个辊实施例,都可用工位102和104每一者的辊14a、14b、16a和16b来执行。因此, 针对片材26所讨论的任何厚度变化都可在分别来自第一和第二工位102和104的片材26a 和26b中找到。还可向系统100加入一个或多个类似于工位102和104的另外的形成工位。
在一个示例性的实施例中,胶基糖片材26a离开第一工位102并有效地在第二工位104 下方流过。在离开工位102之后,胶基糖片材26a包括沿着相对上表面67a的厚度变化,这个厚度变化是由辊16a的直径变化赋予的。离开第二工位104的片材26b被堆积或堆叠 在片材26a的表面67a的顶部上,使得表面67a中存在的厚度变化将创建由片材26a的厚 度变化和片材26b的下表面66b限定的通道110。这在图7A最好地示出。当然,除了辊 16a以外,辊14b、辊14a和14b和/或辊14a、14b和16b都还可包括直径变化,从而产生 出分别如图7B、7C和7D的示例性实施例中所示的带通道的片材。虽然在图7B、7C和 7D的示例性实施例中凹入部被显示为对齐的,但是本公开当然还考虑到其中凹入部不对 齐的实施例。另外,并且如上文所提到,经由辊中的通道在片材中创建的隆起部也可在两 个片材之间创建通道。另外,当在多个片材26中创建成型块301时(如在图10A和10B 中显示),可将这些片材进行堆叠,使得每个片材26的成型块301对齐,并且可同时从 每个片材26的卷材303分离。对齐的块301的这个同时分离步骤创建堆叠且分离的胶基 糖块301的多层产品。
应认识到,可在片材26a和26b的接触表面上存在位于胶基糖组合物内的或由所述(一 个或多个)辊赋予的粘合剂,以帮助维持它们之间的接触。另外,可在胶基糖加工的下游 阶段或各阶段之间将另外的糖食组合物(糖果或胶基糖)注入到通道110中,从而改进附着性和风味体验。
对于所有以上讨论的实施例,应认识到,辊14、14a、14b、16、16a和16b(或运送 咀嚼型胶基糖贯穿系统10、100的运送装置90)都可包括能够冷却胶基糖片材26、26a(在 从胶基糖料团转移到胶基糖片材的过程中)从而固化片材26、26a内的厚度变化的温度控 制部件。为了赋予这种温度转移,至少下辊16、16a、16b(也许两种辊)可进行冷却(或 加热)。在一些实施例中,上辊14、14a、14b和下辊16、16a、16b每一者都可提供有内 部通道,加热或冷却流体如调温水(tempered water)或较低凝固点的流体在其中流过以加热 或冷却所述辊。因此,所述辊的表面温度可从-15℃至90℃进行调节。
图1和7的系统10和100中还可包括位于压实辊93下游的刻划辊91(不过这样的 辊当与在料流方向68上创建厚度变化的系统一起使用时可能相对于所创建的厚度变化需 要修改)和横向划分辊92,以及冷却隧道94。刻划辊91和横向划分辊92将胶基糖片材 26、26a划分为单独的片材95。片材95被运送到冷却隧道94,其中片材95可用强迫通风 从顶侧和底侧同时冷却。随着片材95在冷却隧道94中进一步进行调理,片材95的胶基 糖材料充分变硬至足以进行堆叠,以便维持形状和使材料蠕变最小化。在一个实施例中, 冷却隧道94被构造成将胶基糖片材95调理至低达约0℃至15℃的温度。然后将片材95 堆叠成胶基糖片材叠堆96并转移进行后续的包装流程。在其它实施例中,冷却隧道94可 布置在系统10、100中的不同位置。例如,冷却隧道94可布置在压实辊93和划分辊92 之间,使得胶基糖片材先进行冷却再进行刻划和/或切割。作为另一种选择,系统10、100 可包括另外的划分和/或切割辊和用于在单条生产线中生产包装的胶基糖产品的包装设 备。
在一些实施例中,所述可选的刻划辊和划分辊可用其它胶基糖切割方案代替,如降落 辊(drop-roller)、冲剪机、制粒机或其它类似的胶基糖切割设备。故此,可将系统10和100 所生产的片材26切割成包括以上讨论的厚度变化的咀嚼型胶基糖块。
本文引用的所有参考文献,包括出版物、专利申请和专利在内,都以引用方式并入本 文,犹如每个参考文献都单独地和具体地被指明以引用方式并入且在本文中整体阐述。
在描述本发明的上下文中(尤其在所附权利要求书的上下文中)术语“一”、“一种”、 “所述”以及类似指示物的使用应被理解为涵盖单数和复数含义两者,除非本文中另有说明 或上下文明显抵触。术语“包含”、“具有”、“包括”和“含有”应被解释为开放式术语(即, 意为“包括但不限于”),除非另有指明。除非本文另有说明,本文对数值范围的叙述仅仅 意图作为个别地提及被归入该范围内的每个单独数值的简略方法,并且每个单独数值被并 入本专利说明文件中,犹如它被个别地在本文中叙述。本文描述的所有方法都可按任何合 适的顺序执行,除非本文中另有说明或上下文明显抵触。除非另有声明,本文提供的任何 和所有例子或示例性语言(例如,“如”)的使用都意图仅仅为了更好地阐明本发明,而非 对本发明的范围加以限制。本专利说明文件中没有任何语言应被解释为表明任何非要求权 利保护的要素对于本发明的实施是必要的。
本文中描述了本发明的优选实施例,包括发明人已知的实施本发明的最佳方式。对本 领域的技术人员来说,在阅读前面的描述后,那些优选实施例的变型形式将变得显而易见。 发明人预期本领域的技术人员会适当采用这些变型形式,并且发明人意图本发明以除本文 所描述的具体方式之外的方式进行实施。相应地,在得到适用的法律允许的前提下,本发 明包括所附的权利要求书中所陈述的主题的所有修改形式和等同物。此外,本发明涵盖以 上描述的要素在本发明所有可能的变型形式中的任何组合,除非本文中另有说明或上下文 明显抵触。
Claims (17)
1.一种形成咀嚼型胶基糖产品的方法,所述方法包括:
提供包括至少一个辊的胶基糖形成系统;
使胶基糖组合物在料流的方向朝向所述形成系统移动并通过所述形成系统;
经由所述形成系统的所述至少一个辊在所述料流的所述方向上并且在离开所述料流的方向上在所述胶基糖组合物中创建多个厚度变化。
2.根据权利要求1所述的方法,其中所述胶基糖组合物中的所述多个厚度变化通过所述至少一个辊中的直径变化被创建。
3.根据权利要求1所述的方法,其中所述形成系统是第一辊和第二辊,在所述第一辊和所述第二辊之间有一间隙,并且其中所述胶基糖组合物中的所述多个厚度变化通过所述第一辊和所述第二辊之一者或两者中的直径变化被创建。
4.根据权利要求3所述的方法,所述方法还包括在所述多个厚度变化的所述创建期间以相同的旋转速度运转所述第一辊和所述第二辊。
5.根据权利要求3所述的方法,其中所述第一辊和所述第二辊之两者包括所述直径变化,并且所述第一辊中的所述直径变化包括与所述第二辊中的所述直径变化相同的尺寸,并且所述第一辊中的所述直径变化与所述第二辊中的所述直径变化是旋转对齐的。
6.根据权利要求1所述的方法,其中所述胶基糖组合物沿着所述厚度变化在所述料流的所述方向上和离开所述料流的所述方向上被分离成胶基糖丸。
7.根据权利要求6所述的方法,其中所述胶基糖丸包括约0.3mm至10mm之间的最大厚度。
8.根据权利要求1所述的方法,其中所述胶基糖组合物包括等于或小于所述胶基糖丸的最终厚度的最大厚度。
9.一种形成咀嚼型胶基糖产品的方法,所述方法包括:
提供包括两个辊的胶基糖形成系统;
使胶基糖组合物在料流的方向朝向所述形成两个辊之间的间隙移动并通过所述形成两个辊之间的间隙;
从所述胶基糖组合物分离或基本上分离多个胶基糖块,所述分离或基本上分离在所述两个辊之间的所述间隙处发生。
10.根据权利要求9所述的方法,其中所述多个胶基糖块中的每一个都被分离或基本上分离成符合期望的形状。
11.根据权利要求9所述的方法,其中所述多个胶基糖块包括约0.3mm至10mm之间的最大厚度。
12.根据权利要求9所述的方法,其中所述胶基糖组合物包括等于或小于所述胶基糖块的最终厚度的最大厚度。
13.根据权利要求9所述的方法,其中基本上分离的所述胶基糖块经由薄的卷材保持连接,所述薄的卷材包括小于所述多个胶基糖块的厚度的30%的卷材厚度。
14.根据权利要求9所述的方法,从所述胶基糖组合物所述分离或基本上分离所述胶基糖块经由所述两个辊之一者或两者的隆起部或凹入部发生。
15.根据权利要求9所述的方法,其中所述胶基糖块是丸形的。
16.根据权利要求9所述的方法,所述方法还包括在从所述胶基糖组合物所述分离或基本上分离所述多个胶基糖块期间以相同的旋转速度运转所述两个辊。
17.根据权利要求9所述的方法,其中所述两个辊的两者包括直径变化,并且所述两个辊中的所述直径变化被提供具有相同的尺寸并且是彼此旋转对齐的。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261703837P | 2012-09-21 | 2012-09-21 | |
| US61/703,837 | 2012-09-21 | ||
| CN201380046385.9A CN104640455B (zh) | 2012-09-21 | 2013-09-19 | 先进的胶基糖形成 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380046385.9A Division CN104640455B (zh) | 2012-09-21 | 2013-09-19 | 先进的胶基糖形成 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107259058A true CN107259058A (zh) | 2017-10-20 |
Family
ID=49274887
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710386468.2A Pending CN107259058A (zh) | 2012-09-21 | 2013-09-19 | 先进的胶基糖形成 |
| CN201380046385.9A Active CN104640455B (zh) | 2012-09-21 | 2013-09-19 | 先进的胶基糖形成 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380046385.9A Active CN104640455B (zh) | 2012-09-21 | 2013-09-19 | 先进的胶基糖形成 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150250202A1 (zh) |
| EP (2) | EP3262951B1 (zh) |
| JP (3) | JP6068643B2 (zh) |
| CN (2) | CN107259058A (zh) |
| BR (1) | BR112015006281A2 (zh) |
| ES (2) | ES2656236T3 (zh) |
| MX (2) | MX364132B (zh) |
| PL (2) | PL3262951T3 (zh) |
| RU (1) | RU2015108378A (zh) |
| WO (1) | WO2014047263A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011090520A1 (en) * | 2010-01-21 | 2011-07-28 | Kraft Foods Global Brands Llc | System and method of forming and sizing chewing gum and/or altering temperature of chewing gum |
| RU2559405C2 (ru) | 2011-03-11 | 2015-08-10 | ИНТЕРКОНТИНЕНТАЛ ГРЕЙТ БРЭНДЗ ЭлЭлСи | Способ и устройство для изготовления многослойных кондитерских изделий |
| MX2014000819A (es) | 2011-07-21 | 2014-02-27 | Intercontinental Great Brands Llc | Conformacion y enfriamiento de goma avanzados. |
| JP2017511689A (ja) | 2014-03-03 | 2017-04-27 | インターコンチネンタル グレート ブランズ エルエルシー | 可食物を製造するための方法 |
| PL3142493T3 (pl) | 2014-05-16 | 2021-05-04 | Intercontinental Great Brands Llc | Zaawansowane formowanie gum do żucia |
| MX381443B (es) * | 2014-05-20 | 2025-03-12 | Intercontinental Great Brands Llc | Metodo altamente eficaz de revestimiento de polvo para mejorar procesos y envasados. |
| WO2015179630A1 (en) * | 2014-05-23 | 2015-11-26 | Intercontinental Great Brands Llc | System and method for manufacturing chewing gum with scoring |
| JP6539841B2 (ja) * | 2015-09-25 | 2019-07-10 | 株式会社オーディオテクニカ | 食品成形用圧延ローラ、食品成形装置 |
| CN111527029A (zh) | 2018-01-05 | 2020-08-11 | 洲际大品牌有限责任公司 | 在未经调理的情况下包装食品 |
| JP7479445B2 (ja) * | 2019-07-30 | 2024-05-08 | インターコンチネンタル グレート ブランズ エルエルシー | 効率的なペレット製造のためのシステム及び方法 |
| USD1081739S1 (en) * | 2021-04-06 | 2025-07-01 | Altria Client Services Llc | Die for gum forming |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2206437A (en) * | 1939-02-02 | 1940-07-02 | Manning Maxwell & Moore Inc | Instrument cap |
| US5972392A (en) * | 1997-06-24 | 1999-10-26 | Wrico Packaging | Embossed chewing gum product and method for manufacturing same |
| CN1829447A (zh) * | 2003-07-28 | 2006-09-06 | Wm.雷格利Jr.公司 | 口香糖胶基以及口香糖组合物 |
| WO2011090520A1 (en) * | 2010-01-21 | 2011-07-28 | Kraft Foods Global Brands Llc | System and method of forming and sizing chewing gum and/or altering temperature of chewing gum |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB359458A (en) * | 1930-07-17 | 1931-10-19 | Gilbert Barklay Mustin | Improvements in chewing gum and the methods of making the same |
| US3492131A (en) | 1966-04-18 | 1970-01-27 | Searle & Co | Peptide sweetening agents |
| JPS476226Y1 (zh) * | 1969-01-23 | 1972-03-03 | ||
| US4136163A (en) | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
| GB1421743A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Ingestible topical and other compositions |
| CA1027347A (en) | 1972-07-20 | 1978-03-07 | David G. Rowsell | Compounds having a physiological cooling effect and compositions containing them |
| FR2444080A1 (fr) | 1978-12-11 | 1980-07-11 | Roquette Freres | Hydrolysat d'amidon hydrogene non cariogene pour la confiserie et procede de preparation de cet hydrolysat |
| JPS5888334A (ja) | 1981-11-20 | 1983-05-26 | Takasago Corp | 3−l−メントキシプロパン−1、2−ジオ−ル |
| AU570286B2 (en) | 1983-12-01 | 1988-03-10 | Nabisco Brands Incorporated | Sweetening chewing gum with l-aspartic acid derivatives |
| ZA849902B (en) * | 1984-01-31 | 1985-08-28 | Warner Lambert Co | Multi-layered chewing gum composition having different rates of flavour release |
| US4971806A (en) * | 1984-01-31 | 1990-11-20 | Warner-Lambert Company | Multi-layered chewing gum composition having different rates of flavor release |
| US4555407A (en) * | 1984-12-24 | 1985-11-26 | General Foods Corporation | Continuous chewing gum method |
| US4619834A (en) | 1985-05-06 | 1986-10-28 | General Foods Corporation | Sweetening with L-aminodicarboxylic acid aminoalkenoic acid ester amides |
| US5217735A (en) | 1986-10-22 | 1993-06-08 | Wm. Wrigley Jr. Company | Method of making chewing gum with delayed release ingredients |
| US4981698A (en) | 1986-12-23 | 1991-01-01 | Warner-Lambert Co. | Multiple encapsulated sweetener delivery system and method of preparation |
| US4997659A (en) | 1989-03-28 | 1991-03-05 | The Wm. Wrigley Jr. Company | Alitame stability in chewing gum by encapsulation |
| DE4110973A1 (de) | 1991-04-05 | 1992-10-08 | Haarmann & Reimer Gmbh | Mittel mit physiologischem kuehleffekt und fuer diese mittel geeignete wirksame verbindungen |
| US5227154A (en) | 1991-08-22 | 1993-07-13 | The University Of Melbourne | Phosphopeptides for the treatment of dental calculus |
| US5300305A (en) | 1991-09-12 | 1994-04-05 | The Procter & Gamble Company | Breath protection microcapsules |
| US5192561A (en) | 1991-09-19 | 1993-03-09 | Wm. Wrigley Jr. Company | Aspartame stability in chewing gum using an acid gelatin system |
| US5164210A (en) | 1991-10-08 | 1992-11-17 | Wm. Wrigley Jr. Company | Zein/shellac encapsulation of high intensity sweeteners in chewing gum |
| US5378131A (en) | 1993-02-18 | 1995-01-03 | The Wm. Wrigley Jr. Company | Chewing gum with dental health benefits employing calcium glycerophosphate |
| US5436013A (en) | 1993-03-02 | 1995-07-25 | Wm. Wrigley Jr. Company | Process for manufacturing wax-free chewing gums with fast set-up times |
| US7112345B1 (en) * | 1993-04-07 | 2006-09-26 | Wm. Wrigley Jr. Company | Multi-Phase sheeted chewing gum and method and apparatus for making |
| US5562936A (en) | 1993-09-24 | 1996-10-08 | Wm. Wrigley Jr. Company | Continuous chewing gum base manufacturing process using highly distribute mixing |
| US5626892A (en) * | 1993-11-24 | 1997-05-06 | Nabisco, Inc. | Method for production of multi-flavored and multi-colored chewing gum |
| EP0672354B1 (en) | 1994-03-18 | 2000-07-12 | Ajinomoto Co., Inc. | Proteinaceous material for enhancing food taste quality |
| JP2983455B2 (ja) * | 1995-08-30 | 1999-11-29 | 鐘紡株式会社 | チューインガムチップの製法及びそれに用いる装置 |
| US20050202118A1 (en) | 1996-10-28 | 2005-09-15 | Johnson Sonya S. | Chewing gum products containing trigeminal stimulant and method of making the same |
| US7025999B2 (en) | 2001-05-11 | 2006-04-11 | Wm. Wrigley Jr. Company | Chewing gum having prolonged sensory benefits |
| US5971739A (en) * | 1996-12-31 | 1999-10-26 | Hoffman; Earl Roger | Gum processing and packaging system |
| US6627233B1 (en) | 1997-09-18 | 2003-09-30 | Wm. Wrigley Jr. Company | Chewing gum containing physiological cooling agents |
| US7244454B1 (en) | 1997-12-03 | 2007-07-17 | Wm. Wrigley Jr. Company | Chewing gum product including encapsulated aspartame and sodium bicarbonate and process of preparing |
| US6692778B2 (en) | 1998-06-05 | 2004-02-17 | Wm. Wrigley Jr. Company | Method of controlling release of N-substituted derivatives of aspartame in chewing gum |
| US6235318B1 (en) | 1999-01-21 | 2001-05-22 | Charles M. Lombardy, Jr. | Effervescent chewing gum |
| US6846500B1 (en) | 1999-03-25 | 2005-01-25 | Cadbury Adams Usa Llc | Oral care chewing gums and method of use |
| US6838431B2 (en) | 1999-07-27 | 2005-01-04 | Pacific Health Laboratories, Inc. | Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety |
| US6582738B2 (en) | 1999-09-13 | 2003-06-24 | Deseret Laboratories, Inc. | Process for preparing chewing gum containing a nutritional supplement |
| KR100744986B1 (ko) | 1999-11-29 | 2007-08-02 | 교와 핫코 푸드 가부시키가이샤 | 식염미 증강방법, 식염미 증강제, 식염미 조미료 및식염미 증강식품 |
| US6780443B1 (en) | 2000-02-04 | 2004-08-24 | Takasago International Corporation | Sensate composition imparting initial sensation upon contact |
| US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
| US6471945B2 (en) | 2000-03-10 | 2002-10-29 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
| US6479071B2 (en) | 2000-03-10 | 2002-11-12 | Warner-Lambert Company | Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| US6485739B2 (en) | 2000-03-10 | 2002-11-26 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
| DE10035461B4 (de) * | 2000-07-21 | 2004-03-11 | Sollich Kg | Verfahren und Vorrichtung zum Ausformen einer Süßwarenmasse |
| US6280780B1 (en) * | 2000-08-24 | 2001-08-28 | Warner-Lambert Company | Method and apparatus for continuously forming coated center-filled gum products |
| EP1317185B1 (en) | 2000-09-12 | 2008-02-13 | Wm. Wrigley Jr. Company | Chewing gum formulations including encapsulated aspartame and sodium pyrophosphate |
| AU2002232575A1 (en) | 2000-12-15 | 2002-06-24 | Pacifichealth Laboratories, Inc. | Nutritional composition for improving the efficacy of a lipase inhibitor |
| US6878390B2 (en) | 2001-10-12 | 2005-04-12 | Kraft Foods Holdings, Inc. | Segmented rolled food item |
| US20030157213A1 (en) | 2002-02-19 | 2003-08-21 | Jeffrey Jenkins | Nutrient chewing gum |
| US20030215417A1 (en) | 2002-04-18 | 2003-11-20 | The Procter & Gamble Company | Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material |
| CN1723011A (zh) | 2002-06-25 | 2006-01-18 | Wm·雷格利Jr·公司 | 含有厚朴提取物的口气清新和口腔清洁产品 |
| EP1565065B1 (en) | 2002-07-23 | 2006-09-13 | Wm. Wrigley Jr. Company | Encapsulated flavors and chewing gum using same |
| US7445769B2 (en) | 2002-10-31 | 2008-11-04 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces and methods of making and using the same |
| US6685916B1 (en) | 2002-10-31 | 2004-02-03 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces, and methods of making and using the same |
| US7390518B2 (en) | 2003-07-11 | 2008-06-24 | Cadbury Adams Usa, Llc | Stain removing chewing gum composition |
| DE10338217B3 (de) * | 2003-08-20 | 2005-01-05 | Sollich Kg | Verfahren und Vorrichtung zur Herstellung eines Produkts aus Süsswarenmasse |
| US20050112236A1 (en) | 2003-11-21 | 2005-05-26 | Navroz Boghani | Delivery system for active components as part of an edible composition having preselected tensile strength |
| US7442026B2 (en) * | 2004-08-23 | 2008-10-28 | Wm. Wrigley Jr. Company | Apparatuses for producing alternatively shaped confectionary products |
| WO2007056685A2 (en) | 2005-11-04 | 2007-05-18 | Wm. Wrigley Jr. Company | Apparatus for producing a center-filled confectionery and method |
| RU2008130931A (ru) * | 2005-12-30 | 2010-02-10 | Вм Ригли Дж. Компани (Us) | Многофазный кондитерский продукт с гель-компонентом и способ его получения |
| CN101415336A (zh) | 2006-03-31 | 2009-04-22 | Wm.雷格利Jr.公司 | 长持续时间包封调味剂和使用该调味剂的口香糖 |
| US20080166449A1 (en) | 2006-11-29 | 2008-07-10 | Cadbury Adams Usa Llc | Confectionery compositions including an elastomeric component and a saccharide component |
| CN102046020B (zh) * | 2008-04-18 | 2016-10-26 | Wm.雷格利Jr.公司 | 口香糖的制造 |
| BE1018217A7 (nl) * | 2008-07-15 | 2010-07-06 | Laureyssens Dirk | Kauwgum variaties. |
| EP2364095B1 (en) * | 2008-11-28 | 2018-03-14 | Mondelez Japan Limited | Multi-region confectionery composition and method |
| US8226401B2 (en) * | 2009-01-12 | 2012-07-24 | Kraft Foods Global Brands Llc | Gum manufacturing system with loafing and conditioning features |
| US20120015071A1 (en) | 2009-02-10 | 2012-01-19 | Omar Ortega | Coated confectionery and chewing gum compositions and methods for making them |
| US8920856B2 (en) | 2009-10-08 | 2014-12-30 | Intercontinental Great Brands Llc | Co-extruded layered candy and gum apparatus and methods |
| EP2515668B8 (en) * | 2009-12-21 | 2019-04-10 | Intercontinental Great Brands LLC | Coated multi-region confectionery and methods of making the same |
-
2013
- 2013-09-19 ES ES13771024.0T patent/ES2656236T3/es active Active
- 2013-09-19 JP JP2015527688A patent/JP6068643B2/ja active Active
- 2013-09-19 RU RU2015108378A patent/RU2015108378A/ru not_active Application Discontinuation
- 2013-09-19 PL PL17185358.3T patent/PL3262951T3/pl unknown
- 2013-09-19 CN CN201710386468.2A patent/CN107259058A/zh active Pending
- 2013-09-19 CN CN201380046385.9A patent/CN104640455B/zh active Active
- 2013-09-19 ES ES17185358T patent/ES2947229T3/es active Active
- 2013-09-19 EP EP17185358.3A patent/EP3262951B1/en not_active Revoked
- 2013-09-19 BR BR112015006281A patent/BR112015006281A2/pt not_active IP Right Cessation
- 2013-09-19 MX MX2015003635A patent/MX364132B/es active IP Right Grant
- 2013-09-19 US US14/430,083 patent/US20150250202A1/en not_active Abandoned
- 2013-09-19 WO PCT/US2013/060584 patent/WO2014047263A1/en not_active Ceased
- 2013-09-19 EP EP13771024.0A patent/EP2897468B1/en active Active
- 2013-09-19 PL PL13771024T patent/PL2897468T3/pl unknown
-
2015
- 2015-03-20 MX MX2022012116A patent/MX2022012116A/es unknown
-
2016
- 2016-12-22 JP JP2016249450A patent/JP6416859B2/ja active Active
-
2018
- 2018-10-04 JP JP2018189336A patent/JP6656333B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2206437A (en) * | 1939-02-02 | 1940-07-02 | Manning Maxwell & Moore Inc | Instrument cap |
| US5972392A (en) * | 1997-06-24 | 1999-10-26 | Wrico Packaging | Embossed chewing gum product and method for manufacturing same |
| CN1829447A (zh) * | 2003-07-28 | 2006-09-06 | Wm.雷格利Jr.公司 | 口香糖胶基以及口香糖组合物 |
| WO2011090520A1 (en) * | 2010-01-21 | 2011-07-28 | Kraft Foods Global Brands Llc | System and method of forming and sizing chewing gum and/or altering temperature of chewing gum |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6656333B2 (ja) | 2020-03-04 |
| JP6068643B2 (ja) | 2017-01-25 |
| JP2018201529A (ja) | 2018-12-27 |
| RU2015108378A (ru) | 2016-11-10 |
| EP2897468A1 (en) | 2015-07-29 |
| US20150250202A1 (en) | 2015-09-10 |
| MX364132B (es) | 2019-04-12 |
| CN104640455B (zh) | 2017-06-20 |
| WO2014047263A1 (en) | 2014-03-27 |
| ES2656236T3 (es) | 2018-02-26 |
| MX2015003635A (es) | 2015-09-25 |
| JP6416859B2 (ja) | 2018-10-31 |
| JP2015524675A (ja) | 2015-08-27 |
| BR112015006281A2 (pt) | 2017-07-04 |
| MX2022012116A (es) | 2022-11-08 |
| CN104640455A (zh) | 2015-05-20 |
| EP3262951A1 (en) | 2018-01-03 |
| EP3262951B1 (en) | 2023-05-03 |
| EP2897468B1 (en) | 2017-11-08 |
| ES2947229T3 (es) | 2023-08-03 |
| JP2017074067A (ja) | 2017-04-20 |
| PL3262951T3 (pl) | 2023-08-07 |
| PL2897468T3 (pl) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6247267B2 (ja) | 多層菓子の形成システムおよび形成方法 | |
| CN107259058A (zh) | 先进的胶基糖形成 | |
| JP4694619B2 (ja) | エラストマー成分、調理済み糖成分および改善した放出成分を含む菓子組成物 | |
| JP5986147B2 (ja) | チューインガムを形成およびサイズ決定するシステムおよび方法ならびに/またはチューインガムの温度の変更するシステムおよび方法 | |
| JP6251168B2 (ja) | チューインガムを形成する方法 | |
| RU2603030C2 (ru) | Система и способ производства жевательной резинки | |
| CN104068197A (zh) | 包括异麦芽酮糖醇胶基糖区的多区咀嚼型胶基糖组合物 | |
| MX2011003134A (es) | Confiteria y metodos para producir la misma. | |
| CN107581335A (zh) | 先进的胶基糖形成 | |
| CN101389224B (zh) | 填充液体的咀嚼型胶基糖组合物 | |
| CN105101809A (zh) | 用于形成具有至少一种包含物的咀嚼型胶基糖产品的系统和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171020 |
|
| WD01 | Invention patent application deemed withdrawn after publication |